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Increased production of neurotoxic forms of amyloid β (Aβ) peptide via altered 
proteolytic cleavage from its precursor, the amyloid protein precursor (APP), and abnormalities 
in neuronal calcium homeostasis play central roles in the pathogenesis of Alzheimer’s disease 
(AD). Notch1, a membrane receptor that controls cell fate decisions during development of the 
nervous system, has been linked to AD because it is a substrate for the γ-secretase enzyme 
activity that involves the presenilin-1 protein in which mutations cause early-onset inherited AD.  
Numb is an evolutionarily conserved endocytic adapter involved in the internalization of 
transmembrane receptors. Mammals produce four Numb isoforms that differ in two functional 
domains, a phosphotyrosine-binding domain (PTB) and a proline-rich region (PRR). Expression 
of these alternative spliced Numb transcripts is tightly regulated both temporally and spatially 
during development and aberrant Numb isoform expression has been associated with increased 
risk for cancers. Recent studies showed that the PTB domain of Numb interacts with the 
cytoplasmic tails of APP and Notch but the functional relevance of these interactions with 
respect to AD pathogenesis is not clear. In the current study, we proposed to investigate the 
biological consequences of the interaction of the Numb proteins with APP and Notch in neural 
cells stably overexpressing each of the four human Numb proteins.  
Converging lines of evidence indicate that the endocytic pathway is involved in the 
aberrant processing of APP. Yet little is known about the underlying regulatory mechanism of 
APP endocytosis and trafficking. Elucidating the functional consequences of the interaction of 
APP with the Numb endocytic adapter proteins will provide a better understanding of the 
underlying mechanisms of aberrant APP processing. In the first part of our studies, we found that 
expression of the Numb isoforms lacking the insert in the PTB (SPTB-Numb) caused the 
 iii
abnormal accumulation of cellular APP in the early endosomes, and increased the levels of C-
terminal APP fragments and Aβ. By contrast, expression of the Numb isoforms with the insert in 
PTB (LPTB-Numb) leads to the depletion of cellular APP and coincides with significantly lower 
production of APP derivatives and Aβ. The contrasting effects of the Numb isoforms on APP 
metabolism appeared to be independent of the composition of the PRR domain and were not 
attributed to differences in the expression of APP nor the activities of the various APP-
processing secretases.  
Evidence is emerging that Notch signaling plays a role in the regulation of apoptosis in 
neural progenitors and in post-mitotic neurons. Numb has been shown to suppress Notch 
signaling by enhancing endocytosis and degradation of the Notch receptor. Whether the aberrant 
expression of the Numb isoforms leads to aberrant Notch signaling, and how this might promote 
neuronal degeneration is still not known. In the second part of our studies, we found that 
expression of SPTB-Numb protein enhances neuronal vulnerability to serum deprivation-induced 
cell death by a mechanism involving the dysregulation of cellular calcium homeostasis. Neural 
cells expressing SPTB-Numb exhibited markedly higher protein levels of transient receptor 
potential canonical 6 (TRPC6) channels and increased calcium entry in response to store 
depletion. These effects are mediated by Notch1 as pharmacological inhibition of Notch1 
abrogated TRPC6 upregulation. We also found that serum deprivation increased TRPC6 
upregulation by a mechanism dependent on Notch activation. Knockdown of TRPC6 expression 
stabilized intracellular calcium homeostasis and significantly suppressed serum deprivation-
induced death suggesting that Notch-dependent TRPC6 upregulation contributes in part to 
serum-deprivation induced death. Interestingly, expression of LPTB-Numb protein suppressed 
serum deprivation-induced activation of Notch and the subsequent upregulation of TRPC6 and 
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cell death. The latter finding further strengthens the link between the Numb isoform specific 
effect on Notch activation and the Notch-dependent upregulation of TRPC6. Finally, we showed 
that the Numb proteins differentially impact Notch activation by altering the endocytic 
trafficking and processing of Notch. Taken together, these studies demonstrate that aberrant 
expression of the Numb proteins may influence APP metabolism and Notch-mediated cellular 















The eternal human hero who courageously carries out his absurd sentence, clandestinely 








 TABLE OF CONTENTS 
 
LIST OF FIGURES ...................................................................................................x 
LIST OF TABLES.................................................................................................. xii 
CHAPTER I  Numb endocytic adapter proteins regulate the transport and 
processing of the amyloid precursor protein in an isoform-dependent manner: 
Implications for Alzheimer’s disease pathogenesis...................................................1 
Introduction................................................................................................................................. 1 
Materials and Methods................................................................................................................ 6 
Antibodies and reagents.......................................................................................................... 6 
cDNA Constructs .................................................................................................................... 7 
Cell lines and transfections ..................................................................................................... 7 
Treatments............................................................................................................................... 8 
RNA isolation and PCR.......................................................................................................... 8 
SDS-PAGE and Western blotting........................................................................................... 9 
Immunofluorescence microscopy ........................................................................................... 9 
Measurements of sAPP levels............................................................................................... 10 
Aβ40/42 sandwich enzyme-linked immuno-sorbent assay (ELISA) assay.......................... 10 
Measurements of secretase activity ...................................................................................... 11 
Cell surface biotinylation...................................................................................................... 11 
Results....................................................................................................................................... 12 
Expression of Numb proteins alters APP metabolism in a manner dependent upon the PTB 
domain................................................................................................................................... 12 
Expression of Numb proteins alters Aβ  generation in a manner dependent upon the PTB 
domain................................................................................................................................... 13 
Expression of the Numb proteins does not affect the level of APP expression nor the 
proteolytic activities of the APP processing secretases. ....................................................... 16 
 vii
The effects of Numb on APP metabolism is dependent on its interaction with APP and the 
internalization of APP........................................................................................................... 18 
Numb proteins influence the endosomal trafficking of APP ................................................ 18 
Effect of the Numb proteins on the endosomal sorting of APP to the recycling pathway ... 22 
Effects of the Numb proteins on the endosomal sorting of APP to the degradative pathway
............................................................................................................................................... 24 
The proteasome-mediated degradative pathway is not involved in the regulation of APP 
metabolism by the Numb proteins ........................................................................................ 26 
Expression of Numb proteins alters the levels of the Rab family of endocytic regulators... 29 
Stress induces the selective upregulation of SPTB-Numb transcripts.................................. 30 
Discussion................................................................................................................................. 32 
CHAPTER II Effects of Numb isoforms on Notch-dependent upregulation of 
TRPC6 calcium channels .........................................................................................38 
Introduction............................................................................................................................... 38 
Materials and methods .............................................................................................................. 44 
Antibodies and reagents........................................................................................................ 44 
Cell culture and treatments ................................................................................................... 44 
Intracellular calcium measurements ..................................................................................... 45 
Cell death assays ................................................................................................................... 46 
siRNA ................................................................................................................................... 47 
RNA isolation and Real-Time PCR...................................................................................... 47 
Results....................................................................................................................................... 49 
SPTB-Numb is characterized by SOCE and increased expression of TRPC calcium 
channels................................................................................................................................. 49 
Serum deprivation-induced cell death is mediated by TRPC6 upregulation........................ 51 
Notch signaling is enhanced in SPTB-Numb ....................................................................... 55 
Serum deprivation increases Notch signaling in PC12 cells ................................................ 57 
 viii
Suppression of Notch signaling by a  γ-secretase inhibitor attenuates TRPC6 expression in 
SPTB-Numb.......................................................................................................................... 59 
Jagged1- mediated activation of Notch induces TRPC6 upregulation in PC12 cells........... 62 





LIST OF FIGURES 
 
Figure 1. APP processing and amyloid β peptide (Aβ) deposition ................................................ 1 
Figure 2. Sub-cellular localization of APP processing ................................................................... 2 
Figure 3. Numb isoforms and their structural domains .................................................................. 4 
Figure 4.  Isoform specificity in the processing of APP and generation of Aβ by the Numb 
proteins.......................................................................................................................................... 14 
Figure 5. Lack of isoform specificity on the expression of APP and the activities of the APP 
secretases....................................................................................................................................... 17 
Figure 6. Isoform specificity of Numb effects on APP metabolism is dependent on the interaction 
of the Numb proteins with APP and its subsequent internalization.............................................. 20 
Figure 7. Effect of the Numb proteins on the sorting of APP to the recycling pathway .............. 23 
Figure 8. Effect of the Numb proteins on the sorting of APP to the degradative pathway .......... 27 
Figure 9. Effect of the Numb proteins on the levels of small Rab GTPases ................................ 30 
Figure 10. Detection of alternatively spliced Numb transcripts under normal and stressed 
conditions...................................................................................................................................... 31 
Figure 11. Schematic diagram: Numb isoform-specific regulation of APP trafficking and Aβ 
generation...................................................................................................................................... 37 
Figure 12.  Notch signaling activation.......................................................................................... 41 
Figure 13.  Thapsigargin-induced SOCE and TRPC calcium channel expression....................... 50 
Figure 14. TRPC6 upregulation mediates serum deprivation-induced cell death in PC12 cells via 
a mechanism that involves the SPTB isoform of Numb............................................................... 54 
Figure 15. Notch signaling is enhanced in SPTB-Numb.............................................................. 56 
 x
Figure 16. Serum deprivation increases Notch signaling in PC12 cells ....................................... 59 
Figure 17. Notch inhibition abrogates TRPC6 upregulation in SPTB-Numb .............................. 61 
Figure 18. Notch activation induces the expression of TRPC6 in PC12 cells.............................. 63 
Figure 19. TRPC6 upregulation mediates the enhanced SOCE in SPTB-Numb ......................... 66 
Figure 20. Schematic diagram: SPTB-Numb affect the Notch-dependent upregulation of TRPC6 




LIST OF TABLES 
 
Table 1. Oligonucleotide sequences of primers used for Real Time RT-PCR ............................. 48 
CHAPTER I  
NUMB ENDOCYTIC ADAPTER PROTEINS REGULATE THE 
TRANSPORT AND PROCESSING OF THE AMYLOID PRECURSOR 
PROTEIN IN AN ISOFORM-DEPENDENT MANNER: IMPLICATIONS 




The amyloid precursor protein (APP) is an integral transmembrane glycoprotein which is highly 
expressed in the brain and plays an important role in neuronal function 1. The abnormal 
processing of APP to generate the amyloid β-peptide (Aβ) leads to the extracellular neuritic 
plaques characteristic of Alzheimer’s disease (AD) 1-3 (Fig. 1). The rate of Aβ production is 
believed to be a key determinant of the onset and progression of AD. While proteolytic 
processing of APP and characterization of the APP-cleaving enzymes (α-, β- and γ-secretases) 





Figure 1. APP processing and amyloid β peptide (Aβ) deposition 
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Several recent findings support the idea that the intracellular transport and subcellular 
localization of APP are crucial determinants of APP processing and Aβ generation. 4, 5. One 
pathway for Aβ generation involves the re-internalization of membrane-bound full length APP 4, 
5. Endosomes have been shown to be intracellular compartments where the sequential action of 
β-and γ-secretases generates amyloidogenic C-terminal fragments of APP (APP-CTFs) and Aβ 1-
3. APP is also targeted to, and degraded in, the lysosomes 6. On the other hand, cleavage within 
the Aβ region of APP by α-secretase, which prevents the production of Aβ, occurs in a late 
compartment of the secretory pathway such as the Golgi or at the cell surface 7 (Fig. 2). Deletion 
of the APP cytoplasmic tail or inhibition of endocytosis has been shown to reduce Aβ levels 
suggesting that endocytosis is critical for Aβ generation 4, 5, 8. Understanding the mechanisms 
that regulate APP trafficking to distinct subcellular compartments with the different secretase 
activities is important for developing strategies to reduce abnormal processing and to prevent 












Figure 2. Sub-cellular localization of APP processing 
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 Numb is an evolutionarily conserved protein identified by its ability to control cell fate 
in the nervous system of Drosophila 9, 10. Numb contains two protein-protein interaction 
domains, a phosphotyrosine-binding (PTB) domain and a proline-rich region (PRR) that 
functions as an SH3-binding domain 11, 12.  Whereas only one form of Numb has been identified 
in Drosophila, mammals produce four alternatively spliced variants of Numb that differ in the 
length of their PTB (lacking or containing an 11 amino acid insert) and PRR (lacking or 
containing a 48 amino acid insert) domains 11, 12. All Numb proteins contain the NPF 
(asparagine-proline-phenylalanine) and DPF (aspartate-proline-phenylalanine) motifs that are 
critical for interaction with proteins containing the Eps15 Homology (EH) domain and with the 
clathrin protein AP-2, respectively (Fig. 3).  Numb can associate with clathrin-coated pits, 
vesicles and endosomes, suggesting it functions as an endocytic adapter protein 13, 14. Numb 
plays a role in the internalization of receptors that are not only involved in cell-fate decisions 
during CNS development 15, but also in neuronal maturation, differentiation and survival 16, 17. 
Notch is an evolutionary conserved transmembrane receptor that specifies cell fate in a wide 
variety of tissues and organisms through local cell-cell interaction 18.  Numb regulates the 
endocytic and ubiquitin-dependent processing of Notch 19 and consequently the cell fate 
decisions determined by Notch signaling 20, 21.  In maturing neurons, Numb binds to the neural 

















Figure 3. Numb isoforms and their structural domains 
 
 
  Previous work has demonstrated an interaction between APP and Numb in mouse brain 
lysates and in cell culture 24. Truncation and site-directed mutagenesis studies have shown that 
Numb binds to the YENPTY motif within the intracellular domain of APP 24. Several other APP 
binding partners that interact with this motif including X11, Fe65, mDab, C-Abl and JIP-1 have 
been demonstrated to affect endogenous APP localization and processing 25.  Considering that 
Numb is an endocytic adapter protein, we determined whether expression of Numb influences 
the trafficking and processing of APP.  Our results show that expression of Numb isoforms 
lacking the insert in the PTB (short PTB- or SPTB-Numb) caused the abnormal accumulation of 
cellular APP in the early endosomes and increased the levels of C-terminal APP fragments 
(APP-CTFs). By contrast, expression of the Numb isoforms with the insert in PTB (long PTB- or 
LPTB-Numb) causes a significant reduction in the cellular content of APP and APP-CTFs. 
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Interestingly, when cultured primary cortical neurons were subjected to trophic factor 
deprivation, the expression of the SPTB-Numb increased at the expense of LPTB-Numb, 
suggesting that pathophysiological conditions can alter Numb isoform expression in a manner 
that increases amyloidogenic processing of APP. Understanding the function of Numb in the 
trafficking of APP may provide insights into the regulation of APP processing in AD 
pathogenesis and lead to possible AD therapies. 
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 Materials and Methods 
 
Antibodies and reagents 
 
Antibodies used for immunodetection of APP were 6E10 (anti-Aβ 1-17) and 22C11 (anti-
sAPPα) (Chemicon); anti-amino terminus of APP (2.F2.19B4, Chemicon), anti-carboxyl 
terminus of APP (APP643-695) and 4G8 anti-Aβ (17-24) (Signet). The polyclonal antibodies to 
Numb were obtained from Santa Cruz (sc-15590) or Upstate (anti-pan-Numb). The antibodies to 
Rab proteins were: Rab5a (Santa Cruz), Rab4a (Santa Cruz), Rab11 (Santa Cruz) and Rab7 
(Sigma). LAMP-1 antibody was from Santa Cruz. Antibodies to the following tags were: GST 
(glutathione S-transferase; Cell Signaling), HA epitope (Santa Cruz) and Flag epitope (Cell 
Signaling). Other antibodies included: ERK1/2 and phospho-ERK1/2, (Cell Signaling), 
dynamin1 (BD Biosciences), actin (Sigma), ubiquitin (Santa Cruz, P4D1), transferrin receptor 
(Zymed), β-secretase 1 (BACE 1; Sigma), presenilin-1 (PS1; Chemicon), nicastrin (Sigma), 
Aph-1 (Sigma), and Pen-2 (Santa Cruz).  Immunofluorescence-conjugated secondary antibodies 
(Alexa Fluor 488-conjugated goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-goat 
IgG) were obtained from Molecular Probes.  Additional reagents included: Lipofectamine Plus 
reagent (Invitrogen), FuGENE-6 (Roche), EZ-Link Sulfo-NHS-LC-Biotin (Pierce), DAPT 
(Calbiochem), lactacystin, peptide aldehyde N-carbobenzoxyl-l-leucinyl-l-leucinyl-l-leucinal 
(MG-132), chloroquine (Calbiochem) and NH4Cl (Calbiochem). The ECL-Plus kit was obtained 
from Amersham-Pharmacia Biotech. The β-amyloid 1–40 and 1–42 Colorimetric ELISA kit was 
purchased from Biosource International Inc. 
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cDNA Constructs  
 
Expression vectors for all four human Numb isoforms have been described previously 26, 
27. Full-length Numb, PTB deletion mutants of human Numb, or control expression plasmids 
were constructed as in-frame fusions downstream of the FLAG epitope. The plasmid for the 
dominant negative dynamin (dyn 1K44E tagged to HA and EGFP) was a kind gift from Dr. N. 
Bunnett, University of California at San Francisco. The cDNA encoding dyn 1K44E was 
subcloned into the retroviral vector pBabe-puro (Addgene). The construct was transfected 
together with a plasmid encoding the vesicular stomatitis virus membrane glycoprotein (VSV-G) 
envelope into 293T packaging cells (Clontech) using FuGENE-6, and the resulting virus-
containing supernatant was collected at 48 and 72 h after transfection, and used for transduction 
as described 28. Expression of exogenous dyn 1K44E was confirmed by immunoblotting.  
 
Cell lines and transfections 
 
PC12, HEK293 and SH-SY5Y cells were cultured under standard conditions in DMEM 
containing 10% fetal bovine serum (Invitrogen) and maintained at 37 °C in a 5% CO2/95% air 
atmosphere. The PC12 cells stably expressing Numb variants have been described previously 27. 
SY5Y neuroblastoma cells stably transfected with a construct carrying the AD disease-linked 
double (“Swedish”) mutation K595N/M596L in APP were obtained from Dr. W. Araki (National 






Trophic factor withdrawal was accomplished by washing the cells twice with phosphate-
buffered saline (PBS) and then maintaining them in Locke’s buffer 26. DAPT (2µM) was used to 
inhibit γ-secretase activity. To inhibit proteasomes and lysosomes, cells were treated with 
proteasomal inhibitors MG-132 (5 µmol/L) and clasto-lactacystin β-lactone (5 µmol/L), or the 
lysosomal inhibitors chloroquine (100 µmol/L) and NH4Cl (50 mmol/L) for various time periods. 
Inhibitors were resuspended either in dimethylsulfoxide (DMSO) or PBS. Controls were either 
treated with equivalent volumes of DMSO for the proteasome inhibitors or with equivalent 
volumes of PBS for chloroquine stimulations.  
 
RNA isolation and PCR  
 
Total RNA from cells grown on 100 mm dishes was isolated with Trizol (Invitrogen) and 
2μg of RNA was reverse transcribed with Superscript II reverse transcriptase and an oligo-dT 
primer. Quantitative real-time PCR (RT-PCR) analyses of APP, Numb and actin were performed 
using the following pairs of primers: rat APP:5’-CCACTACCACAACTACCACTG-3’ (forward) 
and 5’-CCTCTCTTTGGCTTTCTGGAA-3’ (reverse); rat β-actin: 5’-
TGTGATGGACTCCGGTGACGG-3’ (forward) and 5’-ACAGCTTCTCTTTGATGTCACGC-
3’ (reverse); Rab5A: 5’-AACAAGACCCAACGGGCCAAATAC-3’ (forward) and 5’-
ATACACAACTATGGCGGCTTGTGC-3’; PTB-Numb (forward): 5'-GGAAGTTCTTCAA 
AGGCTTCTTTG-3'; PTB-Numb (reverse): 5'-TTCATCCACAACTCTGAGTCCATC-3'. The 
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Numb primers were designed to flank the alternatively spliced insert in the PTB domain of the 
rat Numb cDNA sequence (Accession No: NM_133287).  
 
SDS-PAGE and Western blotting 
 
Cells were harvested and lysed in buffer (100 mM Tris, pH 6.8, 1% SDS, 10 mM EDTA, 
5 mM EGTA, 2 mM PMSF, 25 µg/ml leupeptin, 5 µg/ml pepstatin). The lysates were cleared by 
centrifugation at 13,000 g for 20 min at 4°C. The protein content of cell lysates was measured 
using the bicinchoninic acid (BCA) reagent (Pierce). Extracts containing 50 µg of protein were 
electrophoresed using Tris-HCl or 16.5 % Tris-Tricine SDS-PAGE (BioRad) under reducing 
conditions and immunoblotted onto nitrocellulose membranes (Bio-Rad). For immunodetection 
of blots, enhanced chemiluminescence (ECL, Amersham) was applied. The optical band 




Following experimental treatments, cells were fixed for 20 min in 4% paraformaldehyde 
in PBS at room temperature, permeabilized (or not) with 0.2% Triton X-100 in PBS, incubated 
for 1 h in blocking solution (0.2 % Triton X-100, 5 % normal horse or goat serum in PBS) and 
then with primary antibody for 1 h in blocking solution at room temperature. The cells were 
washed with PBS and finally incubated with 1 μg / ml Alexa Fluor 488 goat anti-rabbit IgG 
(1 μg / ml, Molecular Probes) in blocking solution at room temperature for 1 h. When double 
labeling was required, cell preparations were incubated with Alexa Fluor 488-conjugated anti-
mouse IgG and rabbit Alexa Fluor 594-conjugated anti-goat IgG (1:200).  Immunostained cells 
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were observed with the appropriate filters on a Leica confocal laser scanning microscope; 
average pixel intensity per cell was determined using software supplied by the manufacturer. 
Appropriate controls, such as secondary antibody alone, indicated a lack of non-specific staining. 
 
Measurements of sAPP levels  
 
For detection of sAPP, the media were collected from cultures of PC12 clones and 
centrifuged at 3,500g (10 min, 4 °C) to remove cell debris. The cleared supernatants were 
concentrated at least 20 fold by ultrafiltration. Cells were harvested, lysed, and prepared for 
protein determinations. Equal amounts of volumes of supernatants, standardized to lysates 
protein, were subjected to SDS-PAGE and immunoblotting analyses. All conditioned media 
values were normalized to total protein lysates. 
 
Aβ40/42 sandwich enzyme-linked immuno-sorbent assay (ELISA) assay 
 
SH-SY5Y cells expressing the Swedish mutant APP were transfected with plasmids for 
the Numb variants or an empty pcDNA3 vector using Lipofectamine reagent according to the 
manufacturer’s specifications. Conditioned media from transfected cells were collected 48 h after 
transfection, and protein inhibitors and AEBSF (Sigma) were added to prevent the degradation of 
Aβ. The concentration of Aβ40/42 in samples and standards was measured in duplicates using 




Measurements of secretase activity 
 
The activity of APP secretases was determined using commercially available secretase 
kits (R&D Systems) according to the manufacturer’s protocol. The method is based on the 
secretase-dependent cleavage of a secretase-specific peptide conjugated to the fluorescent 
reporter molecules EDANS and DABCYL, which results in the release of a fluorescent signal 
that can be detected using a fluorescence microplate reader (excitation at 355 nm /emission at 
510 nm). The level of secretase enzymatic activity is proportional to the fluorimetric reaction.  
 
Cell surface biotinylation 
 
Confluent 10 cm dishes of each of the PC12 clones were washed three times with ice-
cold PBS supplemented with 1 mM Ca2+ and 2 mM Mg2+, and incubated with 1 ml of biotin 
label (Pierce EZ-Link Sulfo-NHS-Biotin) at 2 mg/ml for 0.5 h on ice in the dark on a rotary 
mixer. The reaction was stopped by extensive washing with PBS and quenched with 50 mM 
glycine in PBS. Cell lysates were then immunoprecipitated with strepavidin-coated agarose. The 
precipitated biotinylated proteins were subjected to immunoblotting to analyze the content of 






Expression of Numb proteins alters APP metabolism in a manner dependent 
upon the PTB domain.  
 
To investigate the impact of Numb on APP metabolism, we stably overexpressed each of 
the four human Numb proteins in PC12 cells 26, 27. APP is physiologically processed by α-
secretase or β-secretase resulting in the shedding of nearly the entire ectodomain to yield large 
soluble APP derivatives (called sAPPα and sAPPβ, respectively) and generation of membrane-
tethered carboxyl-terminal fragments of APP (APP-CTFs) that include C83 and C99. The C99 is 
further cleaved by γ-secretase to release the ~4 kDa Aβ peptide and the APP intracellular domain 
(AICD). Stable expression of the SPTB-Numb proteins resulted in a significant accumulation of 
intracellular APP (Fig. 4A) and increased secretion of sAPPα and sAPPβ in the conditioned 
media (Fig. 4B). By densitometric scanning of Western blots, the total amount of APP 
holoprotein in cells overexpressing the SPTB-Numb proteins was increased by four to five fold 
compared to parental control cells and by eight to ten fold compared to the LPTB-Numb clones. 
The increased accumulation of APP was confirmed by immunostaining using antibodies to the 
amino- and carboxyl-termini of APP (Fig. 4B). 
 The intracellular accumulation of APP holoprotein coincided with a significant increase 
in the amount of APP processing products. Both total sAPP and the amount of sAPPα 
immunoprecipitated from the conditioned media with anti-APP antibodies 22C11 and 6E10, 
respectively, were significantly higher in the SPTB-Numb clones. Steady-state levels of the α-
secretase- and β-secretase derived APP-CTFs, C83 and C99, respectively, were also increased in 
lysates, consistent with the ability of the SPTB-Numb proteins to promote non-amyloidogenic 
and amyloidogenic processing pathways (Fig. 4B). The opposite effect was observed in the 
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clones expressing LPTB-Numb; steady state levels of APP holoprotein and APP processing 
products were markedly reduced relative to the parental clones. Only with long exposure times 
could the sAPP and APP-CTFs in the LPTB-Numb clones be detected. In contrast to APP, no 
change in the total levels of the transferrin receptor (TfR; Fig. 4A) was found in the lysates 
suggesting that the observed effects mediated by the Numb proteins were selective for APP. 
Collectively, the data indicate that the Numb proteins that differ in the PTB domain affect the 
processing of APP in a distinct and contrasting manner. 
 
Expression of Numb proteins alters Aβ  generation in a manner dependent upon 
the PTB domain.  
 
Since the Numb proteins differentially affect APP cleavage and the generation of APP-
CTFs, we reasoned that Numb should also influence the generation of Aβ. To test this notion, the 
cDNAs encoding Flag-Numb variants were transfected into SY5Y cells expressing the Swedish 
mutant APP (Fig. 4C). Aβ40 and Aβ42 levels in the conditioned medium 48 h after transfection 
were determined using ELISA measurements. Consistent with the observed effects of Numb on 
the generation of APP-CTFs, we found that the LPTB-Numb proteins suppressed the production 
of Aβ40 and Aβ42 into the conditioned medium, whereas cells expressing the SPTB-Numb 
proteins generated elevated levels of Aβ40 (7.3 pg/ml versus 28.5 pg/ml/protein) and Aβ42 (3.4 

















 (A) Effect of Numb proteins on the amounts of APP and TfR. Representative 
immunoblot showing total levels of APP and TfR protein in the indicated PC12 clones (left 
panels).  Each lane was loaded with 50 µg of protein. The relative amounts of APP and TfR were 
normalized to those of actin. Densitometric analyses were performed on the immunoblots (right 
panel). The values in the histogram represent the mean ± SD n = 3; *p < 0.01; #p < 0.05 
(ANOVA with Scheffe post-hoc tests) relative to empty vector-transfected cells. (B) Effect of 
Numb proteins on the cleavage of APP. APP derivatives in the conditioned medium and in 
lysates of the indicated PC12 clones were quantified by western blot followed by densitometric 
analyses. APP derivatives in conditioned culture medium were immunoprecipitated with an 
antibody to the amino terminal domain of the APP protein (22C11 which precipitates both 
sAPPα and sAPPβ and an antibody to Aβ (6E10; Signet) which recognizes sAPPα. Steady-state 
levels of membrane-associated APP derivatives, C99 and C83, were immunodetected with 
antibodies to the carboxyl terminal domain of the APP protein. The β-actin signal represents the 
internal loading control. Densitometric analyses were performed on the immunoblots (left panel). 
The values in the histogram represent the mean ± SD; n = 3; * p < 0.01; # p < 0.05 (ANOVA 
with Scheffe post-hoc tests) relative to vector-transfected control. Essentially similar results were 
obtained using two additional stable clones. (C) Effect of Numb proteins on the generation of Aβ
peptides. SY5Y cells stably expressing the Swedish mutation of APP were transfected with 
plasmids encoding the Flag-Numb proteins. Conditioned media were harvested and analyzed by 
a sandwich-ELISA for specific quantization of Aβ40 and Aβ42. Expression of Flag-Numb 
proteins was detected by immunoblotting using an antibody to Flag (left panels).The histogram 
shows the amounts of Aβ40 and Aβ42 in the indicated clones (right panels). The values represent 







Expression of the Numb proteins does not affect the level of APP expression nor 
the proteolytic activities of the APP processing secretases.  
 
One possible explanation for the effects of Numb on APP metabolism would be an 
alteration in the expression of APP. The presence of the Numb proteins had no significant effect 
on the levels of APP mRNA (Fig. 5A). We also considered the possibility that the Numb 
proteins might differentially alter the activities or the amounts of the APP processing secretases. 
To investigate the influence of the Numb proteins on APP cleavages, we analyzed the proteolytic 
activities of α-, β-, and γ-secretases using commercially available secretase kits from R&D 
Systems. No significant difference in the proteolytic activities of these secretases was detected 
among the stable clones (Fig. 5B). In addition, we found that levels of BACE1 and of the γ-
secretase components (presenilin-1, nicastrin, APH-1, APH2) were not altered by the expression 
of Numb (Fig. 5C) which further argued against a role of the Numb proteins in regulating the 
proteolytic activities of the secretases.  Collectively, the data suggest that Numb proteins do not 
alter APP metabolism by regulating the expression of APP or the enzymatic activities of the 





Figure 5. Lack of isoform specificity on the expression of APP and the activities of the APP 
secretases 
 
(A) Expression of the Numb proteins did not alter the expression of APP. Semi-
quantitative RT-PCR analysis of APP mRNA in the indicated PC12 clones (left panels). The 
GAPDH signal represents the internal loading control. The values in the histogram are the mean ± 
SD of 3 independent measurements (right panel). Essentially similar results were obtained using 
two additional stably transfected clones. (B) Expression of the Numb proteins did not alter the 
activities of APP processing secretases. The lysates were tested for secretase activities by 
addition of secretase specific peptide substrates conjugated to the reporter molecules EDANS 
and DABCYL (R&D). Fluorescently labeled peptides were detected only upon cleavage by the 
respective secretases. After incubation at 37 °C for 2 h, reactions were transferred to a 96-well 
plate, and fluorescence was measured as described under "Experimental Procedures". The values 
expressed as arbitrary units of fluorescence (AUF), are the mean ± SD of at least 3 independent 
experiments. (C) Numb proteins did not alter the protein level of β-secretase (BACE1) and of the 
components of the γ-secretase complex. Representative immunoblots showing total levels of β-
secretase, presenilin-1, nicastrin, Aph-1, and Pen-2 in the indicated clones. Each lane was loaded 
with 50 µg of protein. Blots were reprobed with an antibody against actin to confirm equal levels 
of protein loading among samples. 
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The effects of Numb on APP metabolism is dependent on its interaction with 
APP and the internalization of APP 
 
Because the interaction of APP with Numb requires the YENPTY motif interacting with 
the PTB domain 24, we determined the effects of a Numb deletion mutant lacking the PTB 
domain (ΔPTB-Numb) on APP metabolism. Quantification of the Western blots (normalized to 
actin) revealed that APP metabolism was not altered in the presence of the ΔPTB-Numb protein 
(Fig. 6A) suggesting that the PTB domain is required for the Numb proteins to influence APP 
metabolism. To determine if the Numb proteins affect the proteolytic processing of APP by 
targeting APP along the endocytic rather than the secretory routes, we examined the effects of a 
dominant negative mutant dynamin (dyn 1K44E tagged to the hemagglutinin epitope (HA) and 
EGFP; a gift from N. Bunnett, U of California at San Francisco) on the ability of each Numb 
protein to modulate APP metabolism. The GTPase dynamin is an important mediator of clathrin 
dependent endocytosis and is required for the internalization of many cell surface receptors 
including Notch and APP 7, 29. As expected, inhibition of endocytosis by mutant dynamin 
induced an elevation of APP holoprotein in all the clones including the LPTB-Numb clones (Fig. 
6B). Total APP protein level in the SPTB-Numb and LPTB-Numb clones was not significantly 
different compared to those in the vector-transfected and parental clones. These results indicate 
that the Numb proteins differentially affect the processing of APP along the endocytic route. 
 
Numb proteins influence the endosomal trafficking of APP 
 
APP undergoes a retrograde transport back to the cell body wherein it is localized in 
Rab5a positive early endosomes 30, late endosomes 8, 31, lysosomes 6 and the Golgi-complex 8. To 
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determine whether the Numb proteins affect the transport of APP to these intracellular 
compartments, we applied immunofluorescence microscopy to examine the subcellular 
localization of APP and Numb. Both these proteins are colocalized on the plasma membrane and 
in vesicular structures in PC12 cells (Fig. 6C). Expression of the SPTB-Numb proteins resulted 
in a marked accumulation of APP in enlarged endosomes (Fig. 6D) that were positively labeled 
for Rab5a (Fig. 6E). Increased APP immunoreactivity was also detected in Rab11-labeled 
recycling endosomes (data not shown) but not in LAMP1-labeled lysosomal compartments of the 
SPTB-Numb clones (data not shown). The subcellular location of APP was similar to that of 
Numb suggesting that Numb interact with APP in the early endocytic compartments. By 
contrast, APP was only faintly detected in the Rab5- (Fig. 6D), Rab11-, and LAMP1-labeled 
compartments (data not shown) in LPTB-Numb clones. Collectively, these data suggest that the 
PTB domain of Numb determines the processing fates of APP by regulating its endosomal 
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Figure 6. Isoform specificity of Numb effects on APP metabolism is dependent on the 




(A) Expression of a Numb protein lacking the PTB domain (ΔPTB-Numb) did not alter 
APP metabolism. Representative immunoblot showing total levels of APP holoprotein in the 
indicated PC12 clones (left panels). Each lane was loaded with 50 µg of protein. APP was 
quantified by western blot with an antibody to the amino terminal domain of the APP protein 
followed by densitometric analyses (right panel). The relative amounts of APP were normalized 
to those of actin. (B) Inhibition of endocytosis by overexpression of mutant dynamin (dyn) 
1K44E abolished the effects of the Numb proteins on APP metabolism. Twenty-four hours after 
transduction, cell lysates were analyzed by immunoblotting followed by densitometry (right 
panel). Representative Immunoblot showing total levels of APP in the indicated PC12 clones. 
Overexpression of the dyn1K44E was confirmed using antibodies raised to dyn1 and to the HA 
tag. The β-actin signal represents the internal loading control. The values in the histogram 
represent the mean ± SD n = 3; *p < 0.01; #p < 0.05 (ANOVA with Scheffe post-hoc tests) 
relative to vector-transfected cells. (C) Localization of APP and Numb in PC12 cells by confocal 
immunofluorescence microscopy. Following fixation and permeabilization, rabbit anti-Numb
and goat anti-rabbit conjugated FITC, and mouse anti-APP (22C11) and goat anti-mouse 
conjugated CY3 secondary antibody were used to detect Numb and APP protein, respectively. 
The right panel shows the merged image of APP and Numb. (D). Intracellular accumulation of 
APP and membrane-associated APP derivatives in a SPTB-Numb (left panel) and LPTB-Numb
clone (right panel). Following fixation and permeabilization, APP was detected with antibodies 
to the carboxyl terminal domains of the APP protein. (E) Localization of APP to endocytic
compartments by confocal immunofluorescence microscopy. Following fixation and 
permeabilization, rabbit anti-Rab5A and goat anti-rabbit conjugated FITC were used to detect 
the early endosomes (green signal), and mouse anti-APP (22C11) and goat anti-mouse 
conjugated CY3 secondary antibody were used to detect APP protein (red signal). The right side 
of each image shows the merged image of APP and Rab5, depicting early endosomes. The 




Effect of the Numb proteins on the endosomal sorting of APP to the recycling 
pathway 
 
  In spite of the accumulation of APP in the enlarged early endosomes (Fig. 6D), SPTB-
Numb clones exhibited increased release of sAPPα and generation of C83 suggesting that APP 
may be preferentially sorted from the early endosomes back to the cell surface where APP is 
cleaved by α-secretase. To evaluate the amount of APP localized on the cell surface, we 
performed cell membrane staining for APP on ice without permeabilization. Only a small 
fraction of APP was detected at the cell surface of parental cells not permeabilized prior to 
antibody incubation (Fig. 7A), consistent with a previous report 5. The fraction of cell surface-
bound APP was markedly higher in the SPTB-Numb clones. As expected, this fraction was 
significantly lower in the LPTB-Numb clones compared to parental cells. As another measure of 
surface APP protein level, proteins on the cell surface were biotinylated with a cell impermeable 
cross-linker, collected with strepavidin-coupled beads, and subjected to immunoblotting. As 
expected, the level of biotinylated plasma membrane-bound APP was significantly higher in 
SPTB-Numb clones (Fig. 7B). By densitometric scanning of Western blots, the amount of cell 
surface-localized APP relative to TfR was approximately five folds higher in cells 
overexpressing SPTB-Numb compared to vector-transfected cells (Fig. 7C). None of the 
biotinylated fractions contained actin consistent with the labeling of only cell surface bound 
proteins (Fig. 7B). 
  To determine whether vesicle recycling contributed to the increased cell surface 
expression of APP in the SPTB-Numb clone, we assessed the impact of a blockade in the 
endosome recycling pathway. Preincubation with monensin, an established inhibitor of the 
recycling pathway that does not interfere with the initial endocytosis of surface receptor proteins 
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32, significantly depleted cell surface APP expression as assessed by surface biotinylation 
followed by immunoblotting of the isolated biotinylated fraction (Fig. 7D). The surface receptor 
depleting effect of monensin on TfR was only slightly reduced in the absence of ligand (Fig. 7D) 
suggesting that the recycling pathway of APP may be mechanistically distinct from that of TfR. 
Quantification of the immunoblots revealed that the changes in the ratio of APP to TfR after 
treatment with monensin was significantly greater in the SPTB-Numb clone compared to the 







Figure 7. Effect of the Numb proteins on the sorting of APP to the recycling pathway 
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(A) The Numb proteins differentially alter the amount of cell surface APP. 
Immunostaining of cell surface APP with an antibody to the amino terminal end of APP. In non-
permeabilized cells (without Triton X-100), significantly more APP is detected on the surface of 
a SPTB-Numb clone compared to a LPTB-Numb clone or a clone transfected with empty vector.
(B) Detection of cell surface APP by biotinylation. Cells were surface biotinylated, lysed, and 
incubated with strepavidin-agarose beads. Biotinylated proteins were immunoblotted with 
antibodies to APP and TfR. (C) Quantitative data showing the ratio of cell surface APP and TfR 
in the indicated clones. Values are the mean ± SD of at least 3 independent 
experiments.*p <0.01; #p< 0.05 (ANOVA with Scheffe post-hoc tests) relative to vector-
transfected cells. (D) Recycling blockade depletes cell surface APP protein level. The indicated 
clones were pretreated with monensin for 60 min at 37°C in DMEM/BSA and incubated in 
DMEM/BSA for 60 min afterwards. Cells were then surface biotinylated using a membrane-
impermeable cross-linker and immunoprecipitated with strepavidin beads. Precipitates were 
subjected to SDS-PAGE, and blots were probed with antibodies to APP and TfR. (E)
Quantitative data showing the changes in the ratio of cell surface APP and TfR in the vector-
transfected and a SPTB-Numb clone after monensin treatment. Values are plotted as percent of 
untreated control (vehicle) and are the mean ± SD of at least 3 independent experiments. * 
p < 0.05 (Student’s t test) relative to vector-transfected  cells. 
 
Effects of the Numb proteins on the endosomal sorting of APP to the degradative 
pathway  
 
To further establish that altered subcellular localization of APP is responsible for the 
differences in its processing fates in the Numb clones, we treated PC12 clones with chloroquine, 
a weak base known to disrupt lysosomal function by blocking organelle acidification 33. 
Treatment with chloroquine (100 µM) for up to 6 h (Fig. 8A) and longer (data not shown) had no 
marked effects on the levels of APP (Fig. 8A) and APP-CTF derivatives (data not shown) in 
SPTB-Numb clones. Similar results were obtained in the presence of ammonium chloride 
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(NH4Cl; 50 mmol/L) confirming that the available pools of APP in the SPTB-Numb cells were 
absent from the lysosomes (Fig. 8B). By contrast, levels of APP protein (Fig. 8A) and APP-CTF 
derivatives (data not shown) in LPTB-Numb clones were significantly increased following 
chloroquine treatment in comparison to vector-transfected cells, ruling out the possibility that 
chloroquine at the concentration of 100 µM was too low to induce APP accumulation in the 
SPTB-Numb clone (Fig. 8A). The same dose of chloroquine also caused marked accumulation 
of APP and APP-CTFs in SH-SY5Y cells stably transfected with the empty vector or with the 
Swedish mutant APP (Fig. 8C). The effect of lysosomal inhibitors on APP protein levels was 
dose-dependent (data not shown). Control incubation of PC12 clones with PBS resulted in 
unchanged levels of APP (data not shown).  To determine that the chloroquine-induced increase 
in APP holoprotein was not related to an effect of Numb on the synthesis of APP, we treated 
cells with the protein synthesis blocker cycloheximide (10 µg/mL) in combination with 
chloroquine. Treatment with cycloheximide for 6 h did not prevent the chloroquine-induced 
increase in APP holoprotein (data not shown). 
   In contrast to lysosomal inhibitors, we found that treatment with the γ-secretase 
inhibitor DAPT markedly enhanced steady state levels of APP and APP-CTFs in the SPTB-
Numb clone (Fig. 8D). The APP-CTFs were only weakly detected in the vector cells but became 
clearly visible, as in the untreated SPTB-Numb clones, after treatment with DAPT which halted 
the cleavage of membrane associated APP-CTFs. The effect of DAPT on APP protein levels was 
dose-dependent (data not shown). In contrast, DAPT failed to elevate levels of APP-CTFs in the 
LPTB-Numb clones. Collectively, our data indicate that the Numb proteins target APP to 
endocytic compartments with distinct APP processing outcomes.  
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The proteasome-mediated degradative pathway is not involved in the regulation 
of APP metabolism by the Numb proteins  
 
Considerable evidence indicates that Numb antagonizes Notch signaling transduction by 
activating the endocytic uptake and degradation of the Notch protein via the proteasomal 
degradation pathway 19, 34. Because of the striking similarities in the proteolytic processing of 
Notch and APP, we hypothesized that the LPTB-Numb proteins may reduce APP protein levels 
by facilitating proteasomal-mediated degradation of APP. To test this hypothesis, we treated the 
stable clones with lactacystin, which inhibits proteasomal degradation of proteins by specifically 
targeting the 20S proteasome, without interfering with lysosomal protein degradation 35. 
Treatment with lactacystin did not result in significant changes in APP protein levels and did not 
impact the generation of APP metabolites in any of the clones tested (Fig. 8E) suggesting that 
the differential effects of the Numb proteins on APP metabolism did not involve the ubiquitin-
proteasome protein degradation pathway. Higher concentrations of lactacystin did not 
significantly induce APP accumulation although the dose of 10 µM was sufficient to induce 
enrichment of ubiquitinated protein species in general, as shown in Western blot analysis 
conducted with an antibody to ubiquitin (data not shown). Collectively, the data indicate that the 
drastic reduction in APP protein level in the LPTB-Numb clones was not due to Numb-mediated 









Figure 8. Effect of the Numb proteins on the sorting of APP to the degradative pathway 
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 (A) Time course of the accumulation of APP and APP-CTFs in LPTB-Numb but not 
SPTB-Numb clones after treatment with a lysosomal inhibitor. The indicated stable PC12 clones 
were treated with chloroquine (100 µM) for 0, 2, and 6 h. Equal amounts of cellular lysates were 
separated by 16.5% Tris-Tricine SDS-PAGE and immunoblotted with an antibody to the 
carboxyl terminal of APP. β-actin was used as the internal loading control. Densitometric 
analyses were performed on the immunoblots (bottom panel). The values in the histogram are the 
mean ± SD of 3 independent measurements. *p< 0.01, #p<0.05 (ANOVA with Scheffe post-hoc 
tests) relative to vector-transfected cells. Similar results were obtained using two additional 
stably transfected Numb clones. (B) Time course of the accumulation of APP in LPTB-Numb
but not SPTB-Numb clones upon treatment with NH4Cl. The indicated clones were treated with 
NH4Cl (50 µM) for 0, 2, 6, and 8 h and processed for immunoblotting using an antibody to the 
carboxyl terminal of APP. (C) Time course of the accumulation of APP and APP-CTFs in SH-
SY5Y cells overexpressing the empty-vector (Vector) or a vector  encoding the Swedish mutant 
APP (APP) upon chloroquine treatment. The indicated SY-SY5Y clones were treated with 
chloroquine (100 µM) for 0, 2, and 6 h. Each lane was loaded with 50 µg of protein. β-actin was 
used as the internal loading control. (D) Time course of the accumulation of APP in the SPTB-
Numb but not LPTB-Numb clones after treatment with the γ-secretase inhibitor DAPT. The 
indicated clones were treated for 0, 2, 6, and 12 h with 10 µM DAPT. Each lane was loaded with 
50 µg of protein. β-actin was used as the internal loading control. Densitometric analyses were 
performed on the immunoblots (bottom panel). Values are the means ± SD of 3 independent 
measurements. *p< 0.01 (ANOVA with Scheffe post-hoc tests) relative to empty vector 
transfected cells. (E) Inhibition of the proteasomes failed to affect the regulation of APP 
metabolism by the Numb proteins. Time course of the levels of APP and APP-CTFs in the 
indicated clones after treatment with 10 µM lactacystin. Equal amounts of protein from each 
sample were immunoblotted to detect APP and APP-CTFs. Each lane was loaded with 50 µg of 
protein and verified with an antibody to actin. Essentially similar results were obtained using two 
additional stably transfected Numb clones.  
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Expression of Numb proteins alters the levels of the Rab family of endocytic 
regulators 
 
Recent studies have demonstrated the involvement of GTP-binding proteins of the Rab 
family in the trafficking and processing of APP 36, 37. Rab proteins are localized in both discrete 
organelles and vesicles where they play key roles in protein trafficking between compartments 
along the secretory and endocytic routes. To determine whether the differential endosomal 
sorting of APP resulted from the altered expression of Rab proteins, we measured protein levels 
of Rab4, Rab5A, Rab7, and Rab11.  Rab5A is a small GTPase localized on early endosomes and 
controls endosome fusion along the endocytic pathway.  Rab4A and Rab11 are regulators of the 
recycling endosomes 36, 37. Protein levels of Rab4A, Rab5A and Rab11 were significantly 
increased in the SPTB-Numb clones relative to control cells (Fig. 9A, B).  By contrast, levels of 
Rab5A and Rab11 were decreased in the LPTB-Numb clones relative to control cells (Fig. 9A, 
B). Levels of Rab7, a regulator of fusion events in the late endocytic pathway, and of LAMP-1, a 
lysosome-associated membrane protein-1 were not different among the stable clones (Fig. 9A, 
B). The changes in the level of the Rab5A protein were not attributable to altered expression as 


















Figure 9. Effect of the Numb proteins on the levels of small Rab GTPases 
 
 (A) Representative Immunoblots showing total amounts of Rab4A, Rab5A, Rab7, 
Rab11, and LAMP1 in the indicated clones. Each lane was loaded with 50 µg of protein and 
verified with an antibody to actin. (B) Densitometric analyses were performed on the 
immunoblots shown in (A). The values in the histogram are the mean ± SD of 3 independent 
measurements.*p< 0.01, #p<0.05 (ANOVA with Dunnett’s Multiple Comparison Test). (C)
Semi-quantitative RT-PCR analysis of Rab5A mRNA in the indicated PC12 clones. The 
GAPDH signal represents the internal loading control.  
 
Stress induces the selective upregulation of SPTB-Numb transcripts 
 
It has been previously reported that alternative splicing of Numb primary transcripts is 
developmentally regulated 37, 38. To determine whether the balance of the alternative spliced 
variants of Numb might be disrupted in cells that were stimulated by apoptosis-inducing agents, 
we designed oligonucleotide primers that bind to the flanking sequences of the insertion in the 
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PTB domain (Fig. 10A). The expected sizes of the amplified PCR products for the SPTB- and 
LPTB-Numb transcripts were 114 and 147 base pairs, respectively. The level of LPTB-Numb 
mRNA which is predominantly expressed under basal condition decreased rapidly upon trophic 
factor withdrawal (TFW), an insult that has previously shown to alter Numb expression 26, 
whereas that of SPTB-Numb accumulates in parallel in stressed cells (Fig. 10B,C). Protein but 
not mRNA levels of APP were also increased in PC12 cells subjected to TFW (data not shown). 
Collectively, these data suggest that cellular could induce the selective upregulation of SPTB-





Figure 10. Detection of alternatively spliced Numb transcripts under normal and stressed 
conditions 
 
(A) Domain structure of the Numb protein. The 11 amino acid insertion in the PTB 
domain is indicated in black. The forward (F) and reverse (R) primers were designed to amplify 
a region flanking the PTB insertion. The specificity of the primer set was confirmed by
performing PCR using an empty plasmid (pCDNA3.1) or plasmids containing each of the four 
Numb isoforms. The expected sizes of PCR fragments were 114 and 147 base pairs for the 
SPTB- and LPTB-Numb transcripts, respectively. (B) Time course of SPTB-Numb and LPTB-
Numb mRNA levels in PC12 cells subjected to trophic factor withdrawal. (C) Densitometric 
analyses were performed on the data shown in (B). The values in the histogram are the mean ± 





Alterations in the endosomal-lysosomal system are believed to occur early in the disease 
process in AD, and may precede the formation of plaques and tangle-associated neuropathology 
in susceptible neuron populations. Endosome enlargement occurs early in sporadic AD, and is 
associated with increased endocytosis and endosome recycling. Aβ immunoreactivity is evident 
in these populations of enlarged endosomes prior to Aβ deposition indicating their potential 
importance for Aβ formation in early AD brain. Much attention has focused on the mechanisms 
that regulate the trafficking of APP to endosomes. In this study, we have uncovered a novel 
function for the Numb adapter proteins as a regulator of endocytic trafficking of APP. Most 
surprisingly, we found that the Numb proteins that differ in the PTB, but not in the PRR domain, 
have opposite effects on the transport and processing of APP. The expression of SPTB-Numb 
proteins resulted in a significant accumulation and persistence of APP holoprotein in the early 
endosomes and increased Aβ secretion. By contrast, expression of LPTB-Numb proteins 
significantly decreased the accumulation of APP and inhibits Aβ secretion. The reduction in Aβ 
secretion was not the result of either the decreased expression of APP or a significant reduction 
in the activities of the APP processing secretases. Furthermore, we demonstrated that all the 
Numb isoforms were capable of interacting with the APP holoprotein, as reported by a previous 
study 24. The APP lowering effect was related to the trafficking role of the LPTB-Numb proteins 
along the endocytic rather than the secretory pathway as treatment with lysosomal inhibitors was 
able to restore endogenous APP holoprotein to the steady state level found in vector-transfected 
cells. It is conceivable that LPTB-Numb but not SPTB-Numb proteins facilitate the delivery of 
APP to the lysosomes for degradation by acidic hydrolases. Taken together, these results indicate 
that APP trafficking differs strikingly in the clones stably expressing the Numb proteins and raise 
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the intriguing possibility that alternative splicing of Numb could alter the trafficking of APP and, 
concomitantly, its processing fate. 
Numb was discovered as an intracellular Notch antagonist 15, 17. Considerable evidence 
over the past years indicated that Numb antagonizes Notch1 signaling by inducing Notch1 
ubiquitination and endocytic degradation of NICD 19, 35. Genetic and biochemical evidence in 
invertebrates has suggested that proteasomal degradation of Notch may be required for the 
cessation of Notch signaling 19, 35. Numb has been shown to recruit the E3 ubiquitin ligase to 
facilitate Notch receptor ubiquitination 19. Several E3 ubiquitin ligases such as LNX, Itch, Siah1, 
and Mdm2 have been shown to associate with Numb 19, 39, 40. To exclude the possibility that the 
LPTB-Numb target APP for proteasomal degradation, we found that proteasomal inhibition had 
no marked effect on the accumulation of APP in the stable clones examined suggesting that 
Numb did not target APP for proteasomal degradation. 
The PTB domain is a protein-protein interaction motif that has been identified in diverse 
group of proteins, of which only a subset is linked to tyrosine kinase-mediated signaling 41. 
Structure-function analyses indicated that the Numb PTB domain can bind to multiple 
conformationally distinct peptide ligands in a phosphotyrosine-independent manner 42-44. The 
PTB domain of Numb has been shown to interact with diverse proteins that determine its 
subcellular localization 42 and protein stability 45. The PTB domain of Numb mediates the 
interaction with the E3 ubiquitin ligases responsible for the ubiquitination of its bound substrates 
such as Notch and Gli 15, 19. Hence, the presence or absence of the insertion within the PTB 
domain could impact the interaction of the Numb proteins with E3 ligases and the targeted 
substrates 15, 46. We found that the insert in the PTB domain did not affect the ability of the 
Numb proteins to interact with APP, in accord with a previous study showing that APP was 
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found in complex with all four mammalian Numb isoforms in cortical lysates 24. The present 
study showed that Numb can bind directly to the YENPTY motif in the cytoplasmic domain of 
APP, an interaction that is not only required for the internalization of cell surface APP, but also 
for its subsequent transport and processing fate.      
The accumulation of APP holoprotein did not correlate with a reduction of Aβ secretion 
which supports the contention that the Numb proteins influence the trafficking of endogenous 
APP along endocytic rather than secretory routes. Additional data showed that inhibition of 
endocytosis by overexpression of a dominant-negative dynamin negates the observed effects of 
the Numb proteins on APP metabolism. Furthermore, treatment of the Numb clones with 
Brefeldin A to inhibit the transport of proteins from ER to Golgi did not show any effect on APP 
accumulation (data not shown) whereas lysosomal inhibitors restored steady state levels of APP 
in the LPTB-Numb clones.   
 The reduced sensitivity of the SPTB-Numb clones to inhibition of lysosomal degradation 
suggests that these Numb proteins may interfere with the transport of APP to the degradative 
pathway. Alternatively, we can not rule out the possibility that these Numb proteins play an 
active role in recycling internalized APP back to the cell surface. This notion is consistent with 
the increased amounts of released sAPPα and intracellular C83 generated by α-secretase 
cleavage which occurs mainly at the cell surface. As dissociation of protein-protein complexes 
favors the recycling pathway, it remains to be elucidated whether the interaction of the Numb 
proteins and APP resulted in conformational changes that are differentially resistant to 
decreasing pH values within the endosomal pathway. Regardless of the underlying molecular 
mechanisms, our data suggest that the Numb proteins differentially alter the endocytic trafficking 
of APP by regulating the endosomal sorting of this protein either to the degradative or recycling 
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pathway. It will be interesting to examine whether the Numb proteins differentially affect the 
trafficking of other receptors with the conserved YENPTY motif such as TrkA, a tyrosine kinase 
receptor whose protein level and responsiveness to nerve growth factor (NGF) were shown to be 
differentially affected by the Numb proteins 27.  
Whether the Numb proteins are directly involved in the active transport of APP remains 
to be elucidated. Intracellular trafficking through the endocytic and recycling pathway are 
regulated by the small GTPase Rab proteins whose altered expression and activity has been 
linked to altered APP metabolism 36, 47, 48. Rab5A upregulation is associated with enlarged early 
endosomes and intracellular accumulation of APP 48. Altered Rab5A activity is responsible for 
the early abnormalities of the neuronal endocytic pathway that are directly related to a rise in Aβ 
levels in brains of AD patients 47, 48. Previous studies demonstrated that Numb interacts with Arf6 
and EHD4 49, proteins that have been associated with the recycling of plasma membrane proteins 
internalized by clathrin-dependent and clathrin-independent endocytic routes 50. Impairments in 
the sorting pathway could also account for the intraneuronal Aβ accumulation in the brains of 
APP mutant transgenic mice and human AD patients 51. We found that level of Rab5A protein 
but not mRNA was elevated in the SPTB-Numb clones suggesting that altered Rab5A function 
in part correlates specifically with altered trafficking of APP. The mechanism(s) whereby 
expression of SPTB-Numb but not increases Rab5A protein level remains to be established. 
At present, the factors that regulate the alternative splicing of the primary Numb 
transcript are not known. It has been shown that the four Numb isoforms are temporally 
regulated and implement distinct developmental functions 37, 38. Ectopic expression of Numb 
isoforms lacking the PRR insertion promotes differentiation whereas those isoforms with the 
insertion direct proliferation. Indeed, the expression of LPRR-Numb isoforms that promote 
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proliferation peaks during the expansion of the neural progenitor pool but is downregulated 
during the course of neuronal development 37, 38. The expression pattern of the Numb proteins 
also varies dramatically between different tissues and cultured cell lines suggesting that Numb 
isoforms may have different functions in different cell types. Our previous study demonstrated 
that Numb protein levels increased in Aβ laden brain regions of a mouse model of AD 26. In this 
study, we found for the first time that pathophysiological conditions can upregulate the 
expression of SPTB-Numb at the expense of LPTB-Numb. This finding raises the intriguing 
possibility that altered Numb expression is an early pathologic event that may be responsible for 
increased Aβ production in patients with AD. 
Although the exact function of APP is still not resolved, experimental evidence suggests 
several activities including synaptogenesis, neurite outgrowth, and cell survival in neurons 1. All 
of these activities may potentially be affected by the presence of Numb proteins determining the 
processing fates of APP. Of particular note is that overexpression of SPTB-Numb in PC12 cells 
enhanced neurite outgrowth 27 and increased vulnerability to apoptotic stimuli by a mechanism 
dependent on the dysregulation of intracellular Ca2+ homeostasis 26, 27. How Numb modulates 
intracellular Ca2+ homeostasis remains to be elucidated. The disruption in Ca2+ signaling may be 
linked to altered APP metabolism 1, 52 suggesting the involvement of altered Numb function or 
expression in the genesis of the AD phenotype. Hence, perturbation of Numb expression may 










































































































Figure 11. Schematic diagram: Numb isoform-specific regulation of APP trafficking and 
Aβ generation 
 
At the pro-neuronal PC12 cells, stress induces the alternative splicing of numb proteins 
that differ at the PTB domain favoring the upregulation of the SPTB isoform. Increases in the 
SPTB isoform of Numb regulates the endocytic trafficking of APP by preferentially shorting 
APP at the early and recycling endosomes. The accumulation of APP at these distinct endocytic 
compartments is accompanied by increased proteolytic processing by β- and γ- secretases and 
increased generation of Aβ at the condition media.  
CHAPTER II 
EFFECTS OF NUMB ISOFORMS ON NOTCH-DEPENDENT 




Numb was first identified in Drosophila as an asymmetrically localized protein involved 
in neural development 10, 53, playing a key role in maintaining neural progenitor cells and 
preventing premature neuronal differentiation 54. Notch is a type-I cell surface receptor that 
regulates cell fate decisions during neurogenesis 55.  Numb accomplishes its effects by 
antagonizing Notch signaling pathways 56, 57 via a mechanism that may involve Numb-mediated 
ubiquitination of  Notch and subsequent degradation of Notch intracellular domain (NICD) 58. 
Mammalian homologues of Numb have been identified suggesting an evolutionary conserved 
function of Numb 54, 59-62. During mouse cortical neurogenesis, Numb is also asymmetrically 
localized, suggesting its potential role in the mammalian nervous system 61. However, Numb is 
also expressed in many adult tissues, suggesting that its functions are not limited to neurogenesis 
57, 60. Structurally, Numb possesses an N-terminus phosphotyrosine binding (PTB) domain 63, a 
proline-rich C-terminus region (PRR) containing SH-3 domain binding sites 60, and an Eps15 
homology (EH) domain binding motif 64. Mammalian Numb is expressed in four isoforms 
differing in the length of the PTB (lacking or containing an 11 amino acid insert) and PRR 
(lacking or containing a 48 amino acid insert) domains 59. Numb proteins containing an insertion 
in the PRR region (LPRR) promote proliferation of neural crest cells, while those lacking the 
insert (SPRR) appear to mediate neural differentiation 65. These results suggest that the functions 
of Numb proteins may be isoform-specific and should be studied separately. PC12 cells stably 
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expressing the Numb isoform that is lacking the PTB insert (SPTB-Numb) stimulate NGF-
induced differentiation and enhance apoptosis induced by NGF deprivation compared to cells 
that stably express the isoform with the PTB insert (LPTB-Numb) 27. The role of PTB isoforms 
in cell fate decisions has been further supported by finding where the SPTB-Numb exhibit 
enhanced elevations of intracellular concentration of calcium ([Ca2+]i) and increased cell death 
sensitivity in response to long-term exposure to amyloid-β peptide (Aβ) 26. The mechanism by 
which Numb modifies calcium homeostasis in SPTB-Numb is not clear, but considering the 
enhanced calcium responses to bradykinin, a know IP3 activator, it may involve enhanced release 
of calcium from endoplasmic reticulum (ER) stores 26. 
The critical role of calcium in many diverse cellular processes including muscle 
contraction, cell death and proliferation, signal transduction and transcriptional regulation has 
been established 66. Calcium is an important intracellular messenger that mediates many 
physiological responses in neurons 67. During normal physiological states, calcium signaling is 
initiated by transient increases in [Ca2+]i that emerge either by calcium entry into the cell from 
the extracellular space and/or by calcium release from the intracellular stores (i.e. ER), 68. 
However, ample data suggest that perturbations of calcium homeostasis are involved in the 
pathogenesis of several neurodegenerative disorders and stroke 69. A variety of different classes 
of calcium channels are found in the plasma membrane, which open in response to voltage-, 
second messenger-,  receptor-, or store-operated mechanisms 70. The transient receptor potential 
canonical (TRPC) calcium channels are one of the seven members of the TRP superfamily which 
are further divided into four subfamilies on the basis of sequence homology: TRPC1, TRPC2, 
TRPC3/6/7 and TRPC4/5 71. TRPC channels are non selective cation channels that are activated 
in response to receptor- or store-operated signals including ER calcium store depletion 72. More 
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specifically, TRPC6 can be directly activated by diacylglycerol (DAG) produced by receptor-
activated phospholipase C (PLC) without any involvement of store-operated mechanisms 73. 
Store-operated calcium entry (SOCE) can be triggered by any process that empties the 
intracellular stores of calcium (i.e. endoplasmic reticulum), regardless of the mechanism by 
which store depletion is accomplished 74, 75. Despite the established role of TRCP6 as a receptor-
operated channel, in pulmonary artery smooth cells, TRPC6 is upregulated in response to chronic 
hypoxia enhancing SOCE 76. Accordingly, ER store depletion with thapsigargin induced 
translocation of TRPC6 channels to the plasma membrane 77. Interestingly, functional TRPC6 
assembles into homo- and heterotetaramers including other members of the TRPC3/6/7 78, 
suggesting that supra-molecular complexes with other adaptor proteins may be present. For 
example, in PC12 cells a TRPC6 multiprotein complex is present containing protein kinase C 
(PKC), FK-506-binding protein-12kDa (FKBP12) and calcineurin /calmodulin 79. The 
physiological role of TRPC6 is largely unknown but growing evidence suggests its involvement 
in various pathological conditions. Six mutations in TRPC6 gene are linked to the human kidney 
disease focal and segmental glomerulosclerosis (FSGS) 80, 81. Three of these mutation result in a 
gain of function and therefore enhance TRPC6 signaling resulting in a pathogenic calcium 
overload leading to dysregulation and cell death 81. Altered expression and function of TRPC6 
channels has also been involved in the development of hypoxic 82 and idiopathic 83 pulmonary 
artery hypertension, angiotensin-induced cardiac hypertrophy 84, Duchenne muscular dystrophy 
85, and Alzheimer’s disease 86. Despite the dispute about the modes of TRPC6 activation, the 
signaling events leading to its transcriptional control are not well understood. 
Notch is a type-I transmembrane receptor present at the plasma membrane as a 
heterodimer (Fig. 12). Notch heterodimerization occurs in the trans-Golgi by a furin-like 
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convertase, during the secretion process 87-89. Notch consists of an ectodomain known as NECD 
(Notch extracellular domain) linked non-covalently to the Notch transmembrane region (NTM) 
90. At the cell surface, Notch can interact with one of its ligands expressed in a neighboring cell 
and get activated 91. In mammals, there are four Notch genes and five genes encoding ligands, 
three Delta-like and two Jagged 92, 93. This interaction renders NTM sensitive to cleavage by 
extracellular metalloproteases of the ADAM/TACE (a desintegrin and metallopeptidase/tumor 
necrosis α converting enzyme) family 94-96. Subsequently, the remaining membrane Notch 
fragment undergoes proteolytic cleavage by a γ-secretase protein complex releasing NICD 97-100. 
NICD translocates to the nucleus where it acts as a co-activator inducing transcriptional 
activation of its target genes 99, 101.  
Fiuza, UM. et al, 2007  
Figure 12.  Notch signaling activation 
 
Notch signaling affects cell fate decisions by critically influencing cell proliferation, 
differentiation, and apoptosis 102. In Drosophila, lack of functional Notch showed an increase 
number of neuroblasts at the expense of epidermal precursors 103. The functions of Notch, 
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however, are not restricted to neurogenesis but also involved in the development of other tissues 
like vessels, thymus, somite, central nervous system, heart, kidney and hematopoietic cells 104-113. 
These functions of Notch are accomplished by tight regulation of its signaling activity that solely 
depends on the generation of NICD and/or its nuclear concentration 98. However, the mechanism 
and conditions by which NICD is generated are of great importance and uncover connections 
between Notch trafficking and signaling activity 114. As previously discussed, Numb is a 
membrane associated protein that inhibits Notch signaling. Numb is acting upstream of the γ-
secretase by physically interacting with Notch and α-adaptin, a component of the AP2 clathrin-
adaptor complex 115, suggesting that Numb may affect the endocytic fate of Notch. Alternatively, 
Numb interacts with the E3 ubiquitin ligase AIP4/Itch to promote ubiquitination, endocytosis 
and degradation of Notch1 58. We have shown that Numb affects the endocytic trafficking and 
proteolytic fate of APP in an isoform specific manner (Kyriazis GA, et al. 2008). More 
specifically, the SPTB-Numb induced the accumulation of APP in the early endosomal and 
recycling compartments accompanied by enhanced proteolytic processing and generation of Aβ. 
Due to the striking processing similarity between Notch and APP it is conceivable that Numb 
may also affect Notch endocytic fate in an isoform specific manner therefore affecting the 
generation of NICD. 
Here we show that SPTB-Numb increase the expression of TRPC6 calcium channels and 
enhance SOCE compared to LPTB-Numb. SPTB-Numb mediate these transcriptional effects on 
TRPC6 by a mechanism that enhances Notch signaling.  Furthermore, neural cells subjected to 
serum deprivation also enhance Notch activity inducing TRPC6 upregulation, effects that are 
preceded by a selective upregulation of the SPTB Numb isoform in expense of the LPTB one. In 
contrast, LPTB-Numb subjected to serum deprivation failed to increase Notch signaling or 
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TRPC6 expression, conferring protection from cell death. Taken together, these results suggest 
an isoform specific role of Numb in modulating calcium homeostasis by a mechanism that 
involves Notch-mediated transcriptional regulation of TRPC6 calcium channels. 
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Materials and methods 
 
Antibodies and reagents 
 
The polyclonal antibodies to the following protein were obtained: Rab5a (Santa Cruz), 
actin (Sigma), Notch1-M20 and Notch1-G20 (Santa Cruz), TRPC6 (Chemicon), TRPC-3,-6 
(gifts from Dr. Schilling). Immunofluorescence-conjugated secondary antibodies (Alexa Fluor 
488-conjugated goat anti-mouse and Alexa Fluor 594-conjugated rabbit anti-goat IgG) were 
obtained from Molecular Probes.  Additional reagents included: Lipofectamine Plus reagent 
(Invitrogen), DAPT (Calbiochem), β-secretase inhibitor IV (Calbiochem), Thapsigargin (LC 
Laboratories).  
 
Cell culture and treatments 
 
PC12 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% 
fetal bovine serum (FBS) (Invitrogen) and maintained at 370C in a 5% CO2 95% air atmosphere. 
PC12 cells stably expressing Numb variants have been described previously 27. Serum 
deprivation was accomplished by washing the cells with phosphate-buffered saline (PBS) and 
then maintained them in serum-free Locke’s buffer 26 for designated times. DAPT (40μM) and 
β-secretase inhibitor IV (10μM) in Opti-MEM I was used to inhibit γ-secretase and  β-secretase 
activity respectively. Thapsigargin (1mM) in Locke’s Ca2+-free was used to inhibit SERCA. 
Jagged-1 peptide (15μM) in DMEM 1% FBS was used to activate Notch1 or appropriate 
scramble control (15μM) after washing cells 5 times with DMEM 1% FBS with 5 min 
incubations at 370C in a 5% CO2 95% air atmosphere  between washes. 
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Intracellular calcium measurements 
 
Cells were cultured on poly-L-lysine-coated glass-bottomed chambers for 24-hr prior to 
intracellular Ca2+ experiments in DMEM + 10% FBS medium. Chambers were mounted onto the 
stage of an Olympus IX-50 fluorescent microscope equipped with an Hg excitation lamp and a 
Myocyte Photometry System (IonOptix, Milton, MA). Cells were superfused with DMEM 
saturated with 95% O2-5% CO2 at 37° and containing 1.8 mmol/L Ca2+. A 90% confluent area of 
20-30 cells was chosen for each experiment. Cells were loaded with Indo-1 by incubation in 
Tyrode’s solution containing (in mmol/L): 138 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 
MgCl2, 10 Hepes, 10 Glucose and 10 μmol/L Indo-1 AM ester (Molecular Probes, Eugene, OR), 
pH=7.4, at room temperature for 35 min. After loading, oxygenated DMEM superfusate at 37° 
was returned for 10 min to wash-out unincorporated dye. Experimental protocols were 
performed in Locke’s solution with Ca2+ (2.0mM), or in Ca2+-free Locke’s solution with EGTA 
(100μM) saturated with 95% O2-5% CO2 at 37°. The 405nm and 475nm emission of Indo-1 
excited at 340nm was collected by a double-photometer unit, and Ca2+ ratio transients were 
recorded in Ion Wizard v4.44 (IonOptix). Fluorescence quench was recorded at 360 nm using 
MnCl2 (Mn2+ 200μmol/L). At the conclusion of all experiments, background numerator and 
denominator counts were measured from a cell-free region of the coverslip.  
For the experimental procedure cells were equilibrated in Ca2+-free Locke’s for 9 min (in 
15 sec intervals) and then thapsigargin (1mM) was added. Measurements were taken for 15min 
and until Ca2+ ratio readings plateau. Cells were then superfused with Ca2+ Locke’s solution. 
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Measurements continued for 6min after Ca2+ peak was recorded. Ratiometric units were 
converted to intracellular Ca2+ concentrations by the Grynkiewicz equation 116: 
[Ca2+] = K d β (R – R min)/(R max – R) 
Ionomycin Ca2+ salt (Sigma) (2 µmol/L in DMEM) was applied before background 
measurements at the conclusion of experiments to obtain R max value. These values were pooled 
for each set of experiments of particular cell type and culture protocol. Ionomycin at higher 
concentrations was observed to cause morphological changes and loss of cell adherence, 
implying lethality. No significant change in R max was observed from 1-5 µmol/L. R min value 
was the mean of background-subtracted ratios obtained from an experimental chamber without 
cells containing Ca2+-free Locke’s and 10 µM Indo-1 Na+ salt. 
 
Cell death assays 
 
Cells were plated on cover slips in 24-wells. Cells were washed with PBS and then 
treated with serum withdrawal medium for designated times. Then cells were washed twice with 
PBS and incubated for 15 minutes at 37°C with 2μm propidium iodide (PI) and 5μg/ml of 
Hoechst dye in PBS. Cells were washed twice with PBS and fixed with 4% paraformaldehyde 
for 1 hour at room temperature. Cover slips were mounted at microscope slides using DPX 
mountant for histology (Fluka) and visualized under a fluorescent microscope (Carl Zeiss). Cells 
were counted and the percent cell death was assessed using a ratio of PI stained cells to total 





Stably transfected PC12 cells with Numb SPTB-Numb were cultured as described above 
to 50% confluency. TRPC6 were knock downed using Stealth siRNA (Invitrogen) (TRPC6: 
AACAUUCCAAAGUCAAGCAUAUUCC), each with its complementary sequence or Stealth 
RNAi Negative control duplex (Invitrogen). Cells plated and transfected with 200nM of siRNA 
and Lipophectamine 2000 (Invitrogen) in Opti-MEM I reduced medium without serum for 24-48 
hours and then subjected to the experimental treatments described above. 
 
RNA isolation and Real-Time PCR 
 
Total RNA from cells grown in 60mm dishes was isolated using Trisol reagent 
(Invitrogen). RNA (2μg) was used to synthesize cDNA using Enhanced Avian HS RT-PCR Kit 
(SIGMA). Real time quantitative PCR was performed using an iCycler (BioRad). Amplification 
was performed in a final volume of 20 µl, including cDNA from the reverse transcribed reaction, 
primer mixture (0.4 µM each of sense and antisense primers), and 12.5 µl 2x SYBR Green Master 
Mix (BioRad). The oligonucleotide primers are listed on Table 1. A serially diluted positive 
control sample was used to create a standard curve and determine the sensitivity and linearity of 
the assay. The standard amplification program included 40 cycles of two steps, each comprising 
heating to 95 °C and heating to 60 °C. Fluorescent product was detected at the last step of each 
cycle. In order to verify the purity of the products, a melting curve was produced after each run. 
To determine the relative quantization of gene expression, the comparative threshold cycle 
method ( CT) was used 117. Variation in RNA quantity and quality was controlled using GAPDH 
or 18S ribosome RNA as internal controls. To calculate a relative Ct for the target molecules 
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(TRPC channels) of interest the CT of the control gene was subtracted from the CT of the gene of 
interest to yield the CT. The final mRNA levels were normalized according to their Ct values 
from the standard curves.  
 











TRPC1  AF061266  Forward  CGACACCTTCCACTCGTTCA  
  Reverse  GCGCTAAGGAGAAGATGTACCAGA  
TRPC2  NM017011  Forward  GTTCCAGTTTCTCTTCTGGACCAT  
  Reverse  CAGCATCGTCCTCGATCTTCT  
TRPC3  AB022331  Forward  CATGCAGTGCAAAGACTTCGTAG  
  Reverse  TTCAGAATGGCTTCCACCTCTT  
TRPC4  NM_080396  Forward  CTCTGCAGATATCTCTGGGAAGAAT  
  Reverse  CACGAGGCAGTATATGAATAAGAACTTT 
TRPC5  AY064411  Forward  TGAAACCCTTCAGTCACTCTTCTG  
  Reverse  AGTAGCTCCCACAAACTCCGTG  
TRPC6  NM_053559  Forward  AGTGTACAGAATGCAGCCAGAAAC  
  Reverse  CAGCCCTTTGTAGGCATTGATC  
TRPC7  XM_225159  Forward  CCCTTTAACCTGGTGCCGA  
  Reverse  TGGAGTTCAGCATGCCCATT  
18S X01117 Forward GTAACCCGTTGAACCCCATT 
  Reverse CCATCCAATCGGTAGTAGCG 
GAPDH NM_017008 Forward ACCCCTTCATTGACCTCAACT 
  Reverse ATGCCAGTGAGCTTCCCGTCAGC 
Numb NM_133287 Forward TCAAGAGGAATGCACATCTGTGAAG 
  Reverse TTCATCCACAACTCTGAGTCCATC 
Numb-LPTB NM_133287 Forward GGAAGTTCTTCAAAGGCTTCTTTG 
  Reverse TTCATCCACAACTCTGAGTCCATC 
Notch1 NM_001105721 Forward TGGAGCTACCTGCACTGACTATC 
  Reverse TCTCCTCGGAGCAGTTAGACC 
HES-1 NM_024360 Forward AAAGATAGCTCCCGGCATTC 




SPTB-Numb is characterized by SOCE and increased expression of TRPC 
calcium channels  
 
We have previously shown that SPTB-Numb demonstrated significantly higher [Ca2+]i 
relative to vector (VT) and LPTB-Numb after treatment with bradykinin 27, an agonist that 
induces calcium release from the ER 118. In order to elucidate whether the bradykinin-evoked 
transient [Ca2+]i increase in SPTB-Numb is due to an enhanced ER calcium pool, VT, SPTB-
Numb, and LPTB-Numb were treated with thapsigargin in calcium-free medium. Thapsigargin 
depletes the ER calcium pool by irreversibly inhibiting the sarcoplasmic/endoplasmic Ca2+-
ATPase pump (SERCA) 119.  SPTB-Numb showed increased calcium concentration after 
thapsigargin treatment compared to VT and LPTB-Numb, indicating that SPTB-Numb have 
enlarged ER calcium pool (Fig 13.a).  Depletion of the endogenous calcium pool induces SOCE, 
via a mechanism that involves specific channels 120. Following depletion of the ER calcium pool 
with TG, calcium (2 mM) was added to the medium to induce SOCE. SPTB-Numb demonstrated 
an enhanced SOCE compared to VT and LPTB-Numb (Fig 13.a). TRPC channels are the most 
likely candidates in mediating SOCE 121, so we measured the expression levels of TRPC 
channels in neural cells stably expressing the Numb isoforms . VT express TRPC1 and moderate 
levels of TRCP3 under basal conditions. TRPC2, -4, -5, and -7 are either minimally expressed or 
undetected (Fig 13.b). Similar findings were observed in the LPTB-Numb. In contrast, in SPTB-
Numb the expression levels of most TRPC channels were increased. Interestingly, the expression 
levels of TRPC3 and TRPC6 channels were 36-fold and 95-fold higher respectively in SPTB-

























































































































































Figure 13.  Thapsigargin-induced SOCE and TRPC calcium channel expression.  
 
(a) Composite traces of [Ca2+]i as a function of time are shown. Cells were perfused with
Locke’s Ca2+-free medium with 100μM EGTA for 6 minutes. Thapsigargin (1mM) was added 
and [Ca2+]i was recorded for 8 minutes. Cells were then perfused with Locke’s Ca2+ (2 mM) and 
SOCE was recorded. (b) Relative expression levels of TRPC channels in the stable PC12 clones 
normalized to 18s mRNA (n=6; *p<0.01 vs. VT and LPTB-Numb). Data are mean ± SEM.     
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Serum deprivation-induced cell death is mediated by TRPC6 upregulation  
 
We have previously shown that SPTB-Numb exhibited increased susceptibility to cell 
death upon serum deprivation  27.  Since SPTB-Numb were found to have high expression levels 
of TRPC3 and TRPC6 we tested whether the increased vulnerability of these clones is mediated 
by these channels. PC12 cells were subjected to serum deprivation for various time points (8, 16, 
and 24 hours) and the expression levels of TRPC3 and TRPC6 were measured. Cell death was 
significantly increased after 24h of serum deprivation compared to untreated control 
(40.8±0.46% vs. 3.6±0.70%) (Fig 14.a). TRPC6 mRNA was increased at 16h (16.51±4.96-fold) 
and 24h (27.32±6.46-fold) of serum deprivation compared to untreated control (Fig 14.b; left 
panel). These mRNA changes in TRPC6 were accompanied by increases in the protein levels 
(4.97±0.38-fold) (center panel), as well as by accumulation of TRPC6 at the cell membrane 
(right panel). No significant upregulation of TRPC3 mRNA was observed (Fig 14.c). 
Interestingly, the serum deprivation-induced upregulation of TRPC6 in PC12 cells was preceded 
(at 8h) by a significant upregulation (1.59±0.07-fold) of the SPTB spliced isoform of Numb (Fig 
14.d). This finding is consistent with the upregulation of TRPC6 observed in SPTB-Numb. In 
order to further elucidate the significance of the SPTB isoform of Numb in the regulation of 
TRPC6 channel, we tested whether similar changes can be observed in the LPTB-Numb, where 
the LPTB isoform of Numb is overexpressed. No significant upregulation of mRNA or protein 
levels of either TRPC6 or TPRC3 was observed (Fig 14.e), suggesting that the presence of the 
SPTB-Numb isoform may be necessary for such changes to occur. Then we tested whether the 
absence of TRPC6 upregulation in LPTB-Numb confers protection against serum deprivation. 
Indeed, cells death was significantly lower in LPTB-Numb (6.34±0.005%) compared to VT 
(20.43±0.048%) after 16h of serum deprivation (Fig 14.f). Moreover, to further confirm the role 
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of TRPC6 upregulation in serum deprivation-induced cell death, we used siRNA to knock down 
TRPC6 and test whether it will decrease the vulnerability of PC12 cells. Treatment with siRNA 
(siTRPC6) successfully reduced the mRNA levels of TRPC6 (0.53±0.15-fold) compared to 
scramble control, after 24h of serum deprivation (Fig 14.g). Cell death was significantly reduced 
in PC12 cells treated with siTRPC6 (37.71±4.56%) compared to scramble (67.15±5.24%) after 
24h of serum deprivation (Fig 14.h). These results suggest that, at least in PC12 cells, TPRC6 
upregulation is implicated in the serum deprivation-induced cell death, and that the SPTB 
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Figure 14. TRPC6 upregulation mediates serum deprivation-induced cell death in PC12 
cells via a mechanism that involves the SPTB isoform of Numb  
 
(a) Percent (%) cell death in VT after 24h of serum deprivation (n=3; *p<0.0001).  (b)
Fold change in TRPC6 mRNA (left panel; n=6) and protein levels (center panel; n=3), and
TRPC6 cellular localization (right panel) in VT after 24h of serum deprivation compared to 
untreated control (*p<0.01). (c) Fold change in TRCP3 mRNA levels in VT after serum 
deprivation compared to untreated controls (n=6). (d) Fold change in the SPTB isoform of Numb 
mRNA levels in VT after serum deprivation compared to untreated controls (n=6; *p=0.003). (e)
Fold change in TRPC3 and TRPC6 mRNA and protein levels in LPTB-Numb after serum 
deprivation compared to untreated controls (n=6). (f) Percent (%) cell death in VT and LPTB-
Numb before and after serum deprivation (n=3; *p<0.0001). (g) Fold change in TRPC6 mRNA 
levels in VT treated with scramble or siRNA directed to TRPC6 (siTRPC6) after 24h of serum 
deprivation (n=3; *p=0.015). (h) Percent (%) cell death in VT treated with scramble or siTRPC6 
before and after 24h of serum deprivation (n=3; *p=0.013). Data are mean ± SEM.  
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Notch signaling is enhanced in SPTB-Numb 
 
Numb is involved in asymmetric cell division during embryogenesis by antagonizing 
Notch signaling 56, 122. It has been suggested that the effects of Numb in regulating Notch-
mediated signaling may be isoform-specific 123. As such, we tested whether Notch signaling is 
differentially affected by overexpressing Numb isoforms. Notch is activated by cleavage and 
release of its intracellular domain (NICD), which then translocates to the nucleus regulating the 
transcriptional activity of target genes 101, 124. Protein levels of NICD were increased in SPTB-
Numb (0.98±0.02) compared to VT (0.77±0.009) and LPTB-Numb (0.61±0.01) (Fig 15.a). 
NICD was largely localized into the nucleus of SPTB-Numb suggesting increased transcriptional 
activity (Fig 15.b). A well reported downstream transcriptional target gene of NICD is 
Hairy/Enhancer of Split-1 (HES-1) 103.  In order to test whether the accumulation of NICD in the 
nucleus of SPTB-Numb clones is accompanied by increased transcriptional activity the relative 
levels of HES-1 mRNA were assessed. We found increased levels of HES-1 expression in 
SPTB-Numb (321.2±39.40) compared to VT (49.00±9.31) and LPTB-Numb (42.02±2.90) (Fig 
15.c), confirming that Notch signaling in SPTB-Numb is enhanced. Then, we tested whether the 
increased activity of Notch in SPTB-Numb is due to altered expression of Notch1 gene, or 
enhanced γ-secretase activity. Neither Notch1 expression (Fig 15.d), nor the activities of γ-
secretase (Fig 15.e) were different in SPTB-Numb compared to VT and LPTB-Numb. 
Considering that Numb promotes ubiquitination, endocytosis and degradation of Notch1 58 we 
speculated that Numb isoforms may differentially affect the endocytic fate of Notch. In SPTB-
Numb, Notch1 co-localized with Rab5a, a marker of early endosome formation (Fig 15.f; left 
column). No such co-localization between Notch1 and Rab5a was observed in LPTB-Numb (Fig 
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15.f; right column). These data suggest that SPTB-Numb may alter Notch activity by promoting 

























































































































































































































































































































Figure 15. Notch signaling is enhanced in SPTB-Numb   
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(a) Protein levels of the active form of Notch (NICD) in vector (VT), SPTB-Numb and 
LPTB-Numb respectively (n=3; *p<0.001). (b) Cellular localization of Notch-NICD (green) in 
VT, SPTB-Numb and LPTB-Numb with Hoechst nuclear staining (blue). Merge of Notch and 
Hoechst nuclear staining (bottom panel). (c) HES-1 and (d) Notch1 mRNA expression in VT, 
SPTB-Numb and LPTB-Numb respectively (n=3; *p<0.001). (e) Relative γ-secretase activities 
in VT, SPTB-Numb and LPTB-Numb respectively. (f) Cellular localization of Rab5 (red) and
Notch (green) with Hoechst nuclear staining (blue). Merge of Rab5, Notch, and Hoechst nuclear 
staining (bottom panel). Data are mean ± SEM.  
 
Serum deprivation increases Notch signaling in PC12 cells 
 
Since Notch signaling is enhanced in cell overexpressing SPTB-Numb and TRPC6 
upregulation mediates the serum deprivation-induced cell death in PC12 cells, we tested whether 
serum deprivation would also activate Notch signaling in PC12 cells. We subjected all clones to 
serum deprivation for various time points and measured the protein levels of NICD. NICD 
protein was significantly increased in VT clones after 16 h (3.86±0.51-fold) and peaked at 24 h 
(5.23±0.32-fold) of serum deprivation (Fig 16.a; center panel). These changes in NICD protein 
induced a significant mRNA upregulation of HES-1 (4.61±1.17-fold) after 16 h of serum 
deprivation (Fig 16.a; right panel). No significant NICD protein upregulation was observed in 
SPTB-Numb or LPTB-Numb upon serum deprivation (Fig 16.a; left panel). It has been 
suggested that Notch1 signaling is required to sustain Notch1 gene transcription via a positive 
feedback loop 125. Consequently, we tested whether the NICD protein upregulation in VT is due 
to enhanced transcriptional regulation of Notch1, or increased proteolytic cleavage of Notch by 
γ-secretases. The mRNA level of Notch1 was increased at 16 h (1.86±0.14-fold) and peaked at 
24 h (3.38±0.67-fold) of serum deprivation, partly explaining the protein upregulation of NICD 
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(Fig 16.b). In contrast, no significant increases in Notch1 mRNA were detected in LPTB-Numb 
consistent with the absence of NICD changes (Fig 16.c).  Moreover, serum deprivation induced a 
time-dependent cellular redistribution of NICD to the nucleus of VT (Fig 16.d), supporting the 
aforementioned increases in NICD protein and Notch transcriptional activity. Collectively, these 
data suggest that the TRPC6 upregulation in SPTB-Numb and in response to serum deprivation 
may be mediated by a mechanism that involves increased Notch activity.       
NICD










































































































































































































































































Figure 16. Serum deprivation increases Notch signaling in PC12 cells 
 
Cells were subjected to serum deprivation or untreated control for various times. (a)
Western blot of NICD levels with actin as loading control in VT, SPTB-Numb and LPTB-Numb
(left panel). Fold change of NICD protein in VT (n=3; *p<0.005) (center panel). Fold change of
HES-1 mRNA in VT (n=3; *p<0.007) (right panel) (b-c) Fold change of Notch1 mRNA in VT 
and LPTB-Numb (n=3; *p=0.001, **p=0.031). (d) Time course of NICD expression and nuclear 
redistribution (green) in VT with nuclear staining (blue). Merge of α-Notch and Hoechst nuclear 
staining (bottom panel). Data are mean ± SEM.  
 
Suppression of Notch signaling by a  γ-secretase inhibitor attenuates TRPC6 
expression in SPTB-Numb 
 
 NICD is released upon proteolytic cleavage by a protein complex that contains γ-
secretase activity 97, 98. As such, we tested whether a know γ-secretase inhibitor, N-[N-(3,5-
difluorophenacetyl-L-alanyl)]-(S)-phenylglycine t-butyl ester (DAPT), can attenuate the 
increased expression of TRPC6 in SPTB-Numb. DAPT (40μM) treatment for 24 h was adequate 
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to decrease the relative expression of HES-1 mRNA (321.2±39.4 vs. 247.8±35.1) in SPTB-
Numb consistent with reduced proteolytic release of NICD and attenuated transcriptional activity 
of its downstream target genes (Fig 17.a). Interestingly, TRPC6 mRNA expression was also 
reduced (241.5±29.9 vs. 102.5±34.6) in SPTB-Numb, but no effects were observed in the mRNA 
expression of TRPC3 (Fig 17.b). These transcriptional changes were also accompanied by 
reduced TRPC6 protein levels (0.51±0.01-fold) in SPTB-Numb compared to untreated control 
(Fig 17.c; right panel). No changes at the protein levels of TRPC3 were observed (Fig 17.c; left 
panel). These data demonstrate that γ-secretase inhibition selectively attenuates the 
transcriptional upregulation of TRPC6 in SPTB-Numb, suggesting an involvement of Notch 
signaling. Several substrates other than Notch are cleaved by γ-secretase, releasing their 
intracellular domain which, in most cases, contains biologically relevant properties 126. APP, a 
well characterized substrate of γ-secretase, is cleaved by β- and γ-secretases releasing  Aβ at the 
extracellular space and the transcriptionally active APP intracellular domain (AICD) in the 
cytoplasm 127. We have shown that Numb regulates APP trafficking and processing, so we tested 
whether a β-secretase inhibitor could also attenuate TRPC6 upregulation in SPTB-Numb. 
Treatment with the β-secretase inhibitor IV (10μM) for 24 h did not effect TRPC3 or TRPC6 
expression (Fig 17.d). These results are consistent with the notion that the effects of DAPT on 
































































































































































































































































































































































































Figure 17. Notch inhibition abrogates TRPC6 upregulation in SPTB-Numb 
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Vector (VT) and SPTB-Numb were treated with DAPT (40μM), or β-secretase inhibitor
IV (10μM) for 24h. (a) HES-1 mRNA expression levels in VT and SPTB-Numb before and after 
DAPT treatment (n=6; *p=0.007). (b) TRPC6 and TRPC3 mRNA expression levels in VT and 
SPTB-Numb before and after DAPT treatment (n=6; *p=0.01). (c) Western blot of TRPC3 and 
TRPC6 protein levels in VT and SPTB-Numb before and after DAPT treatment (left panel). Fold 
change of TRPC6 protein in SPTB-Numb before and after DAPT treatment (right panel) (n=3; 
*p=0.037). (d) TRPC6 and TRPC3 mRNA expression levels in VT and SPTB-Numb before and 
after β-secretase inhibitor treatment (n=3). Data are mean ± SEM.   
 
Jagged1- mediated activation of Notch induces TRPC6 upregulation in PC12 
cells 
 
Since inhibition of Notch signaling attenuated TPRC6 expression in SPTB-Numb we set 
to investigate whether activation of Notch signaling can confer the opposite effects and 
upregulate the transcription of TRPC6 in PC12. In mammals, Jagged-1 is a well characterized 
Notch ligand, which upon binding to Notch receptors induces the release of NICD and therefore 
Notch signaling activation 128.  PC12 cells were treated with either rat Jagged-1 peptide (15μM), 
or a scramble control peptide (15μM) for various time points and the mRNA expression levels of 
HES-1, TRCP3, TRPC6 and SPTB isoform of Numb were measured. Jagged-1 peptide activated 
Notch signaling by inducing HES-1 mRNA expression after 4 h of treatment (1.85±0.10-fold) 
compared to scramble control peptide (Fig 18.a). Similarly, Jagged-1 peptide treatment induced 
TRPC6 mRNA at 4 h (11.83±4.11-fold) compared to scramble control peptide (Fig 18.b). No 
effects on TRPC3 mRNA expression were detected (Fig 18.c). These results suggest that Notch 
selectively upregulates the expression of TRPC6 in PC12 cells. Activation of Notch signaling did 
 62
not affect the expression of SPTB isoform of Numb (Fig 18.d), suggesting that the Notch-




























































































































































































































































































Figure 18. Notch activation induces the expression of TRPC6 in PC12 cells 
PC12 cells (VT) were treated with Jagged-1 peptide (15μM), or scramble control peptide 
(SC) (15μM) for designated times and the expression of various genes was assessed. Fold 
changes in mRNA of (a) HES-1 (n=4; *p<0.001), (b) TRPC6 (n=4; *p=0.015), (c) TRPC3 
(n=4), and (d) SPTB isoform of Numb (n=4) after Jagged-1 treatment compared to scramble 
control (VT SC). Data are mean ± SEM. 
 
Increased levels of TRPC6 channels account for the enhanced SOCE in SPTB-
Numb  
 
We have shown that TRCP6 is upregulated in SPTB-Numb and that DAPT treatment 
attenuates its expression via a mechanism that involves Notch signaling. It is conceivable that the 
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increased levels of TRPC6 calcium channels may partly explain the increased ER calcium pool 
and enhanced SOCE in SPTB-Numb. Therefore, we tested whether DAPT treatment can reduce 
[Ca2+]i in response to thapsigargin treatment by attenuating TRPC6 expression. Changes in 
[Ca2+]i were assessed in vector and SPTB-Numb after treatment with thapsigargin calcium-free 
solution. The calcium response to thapsigargin treatment was reduced in SPTB-Numb pre-treated 
with DAPT for 24 h compared to untreated control (Fig 19.a; left panel). These differences in 
[Ca2+]i after thapsigargin-induced depletion of calcium pool were manifested by a reduced 
calcium peak (374.6±30.42 vs. 205.9±44.96) (Fig 19.a; center panel), as well as by an overall 
attenuated calcium response to thapsigargin, assessed by calculating the area under the curve for 
each treatment (3.87±0.33 vs. 2.5±0.06) (Fig 19.a; right panel). VT pre-treated with DAPT did 
not induce any changes in [Ca2+]i  under similar conditions (Fig 19.b). Additionally, we tested 
whether DAPT treatment would also affect SOCE in VT and SPTB-Numb. Cells were treated 
with thapsigargin in calcium-free solution until steady state was reached. Calcium (2mM) was 
added in the medium and [Ca2+]i was recorded. Pre-treatment with DAPT for 24 h significantly 
decreased SOCE in SPTB-Numb (Fig 19.c), but not in VT (Fig 19.d). In order to exclude the 
possibility that these changes are mediated by an upregulation of proteins that are know to 
facilitate ER calcium uptake and sequestration, we assessed the protein levels of SERCA and 
Grp78/94 respectively.  There were no differences in the protein levels of SERCA and Grp78/94 
(Fig 19.e). Finally, in order to demonstrate the direct role of TRPC6 in enhancing SOCE in 
SPTB-Numb, we used siRNA to knock down TRPC6. The mRNA and protein levels of TRPC6 
were significantly reduced (0.38±0.12-fold and 0.47±0.02-fold respectively) compared to 
scramble (SC) control peptide (Fig 19.f). We set to confirm that the changes in [Ca2+]i upon 
DAPT pre-treatment and thapsigargin-induced calcium depletion specifically reflect calcium 
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influx via TRPC6 channels. We measured the effects of extracellular MnCl2 (Mn2+ 200μM) on 
the rate at which Fura-2 fluorescence at 360nm (F360) was quenched. Mn2+ enters the cell as a 
Ca2+ surrogate and reduces F360 upon binding to the dye. The rate of quenched F360 was assessed 
in the presence of thapsigargin (ER Ca2+ store depletion) to measure Ca2+ influx in SPTB-Numb 
treated with either siTRPC6 or scramble control peptide. Quenching of F360 by Mn2+ was lower 
in siTRPC6 treated SPTB-Numb (shown on the trace are higher F/F0), suggesting that Ca2+ 
influx was significantly lower when TRPC6 was knocked down (Fig 19.g). Collectively, these 
results demonstrate that the TRPC6 upregulation may in part account for the enhanced SOCE 
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Figure 19. TRPC6 upregulation mediates the enhanced SOCE in SPTB-Numb 
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(a) SPTB-Numb were pre-treated with DAPT (40μM) in OptiMEM or OptiMEM alone 
for 24h. Cells were then perfused with Locke’s Ca2+-free medium with 100μM EGTA for 6 
minutes. Thapsigargin (1mM) was added, as indicated, and fluorescent ratio changes from 
baseline (Δ F340/F380) were recorded, in 30 second intervals, until steady state was reached (left 
panel). Ca2+ peak was assessed as the largest change of [Ca2+]i from baseline (n=4; *p=0.36)
(center panel). The area under the curve was calculated as the sum of individual trapezoid areas 
(n=4; *p<0.01) (right panel). (b) Same as described in (a) using VT (n=4). (c) SPTB-Numb were 
pretreated with DAPT (40μM) in OPTIMEM or OPTIMEM alone for 24h. Cells were then 
perfused with Locke’s Ca2+-free medium with 100μM EGTA for 6 minutes and thapsigargin
(1mM) was then added for 20 minutes. Cells were then perfused with Locke’s including Ca2+
(2mM), as indicated, and SOCE was recorded as fluorescent ratio changes from baseline (Δ
F340/F380), in 30 second intervals (n=4; *p<0.02) (left panel). (d) Same as described in (c) using 
VT (n=4). (e) Western blots showing protein levels of SERCA, Grp94/Grp78 and actin as 
loading control among VT, SPTB-Numb and LPTB-Numb. (f) Fold change of TRCP6 mRNA 
(n=6; *p=0.01, left panel) and protein (n=3; *p=0.004, center panel) levels of SPTB-Numb
treated with TRPC6 siRNA (siTRPC6), or scramble (SC) control. Fluorescent intensity and 
localization of TRCP6 in SPTB-Numb treated with siTRPC6 compared to VT or scramble 
control (right panel). (g) Comparison of Mn2+ quenching of Fura-2 fluorescence in SPTB-Numb
treated with siTRPC6 or scramble control. Traces illustrate the time course and magnitude of 
Mn2+ quenching. The fluorescence as a function of time (F) was normalized to the fluorescent 
value measured immediately before the addition of Mn2+ (F0) (n=3; *p<0.05 vs. scramble). Data 




Mammalian Numb produce four isoforms that differ in the length of their PTB and/or 
PRR domains 59, 65. In neural progenitor cells, Numb isoforms containing the long PRR domain 
promote proliferation, while those cells lacking the insert promote cell differentiation 65. In NGF-
induced differentiated PC12, Numb isoform lacking the insert at the PTB domain enhances 
neurite outgrowth compared to the isoforms containing the insert 27. As such, it is conceivable 
that Numb may regulate diverge cell functions in an isoform specific way. We have previously 
shown that Numb modifies neural cell calcium homeostasis in an isoform-specific manner, and 
thereby may regulate cell survival 26. More specifically, SPTB-Numb demonstrated increased 
calcium responses to bradykinin and enhanced [Ca2+]i after serum deprivation. These data 
suggest that Numb may mediate mechanisms that affect the ER calcium pool, thus regulating 
calcium-dependent processes.  
Here we show that Numb affects SOCE in an isoform-specific manner via a mechanism 
that induces transcriptional upregulation of TRPC calcium channels. TRPC belong to the 
superfamily of TRP calcium channels that are activated in response to receptor stimulation and 
activation of different isoforms of protein lipase C (PLC), or activation by diacylglycerol (DAG) 
73, 129, 130. Despite the unequivocal role of TRPC in receptor-mediated calcium entry, their 
involvement  in SOCE has not been well characterized 131, 132. In neuroblasts, serum deprivation 
induces ER store depletion, a process that activates SOCE mechanisms 133. Therefore, we tested 
whether the TRPC calcium channels are involved the serum deprivation-induced susceptibility to 
cell death in neural cells. Serum deprivation selectively upregulated TRPC6 channels in PC12 
cells, consistent with a recent report where chronic hypoxia in pulmonary arterial smooth muscle 
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cells increased TRPC6 leading to enhanced Ca2+ entry through SOCE mechanisms 76. We also 
found that TRPC6 accumulated at the plasma membrane of PC12 consistent with reports 
showing that SOC channels transported in cytoplasmic vesicles fuse with the plasma membrane 
to mediate SOCE 134, 135.  Furthermore, siRNA against TRPC6 significantly protected PC12 cells 
from serum deprivation confirming the selective role of TRCP6 in mediating serum deprivation-
induced cell death by altering calcium homeostasis. Accordingly, siTRPC6 reduced calcium 
influx in SPTB-Numb after calcium store depletion demonstrating that high levels of TRCP6 can 
mediate SOCE mechanisms. Consistent with our findings, TRPC6 channels translocated to the 
plasma membrane in response to store depletion by thapsigargin, indicating a store-dependent 
involvement of TRPC6 channels 136. TRCP6 can be directly activated by receptor-operated 
signaling resulting in activated PLC or increased DAG, without the involvement of internal 
calcium stores 73. Our results however, suggest that TRPC6 is involved in SOCE, induced by 
depletion of ER calcium pool. TRPC6 and TRPC3 are largely non-selective cation channels, 
suggesting that the inward current passing through them can be attributed to Na+ ions 137, 138. 
Along these lines, stimulation of Ca2+ entry via TRPC6 channels in A7r5 smooth muscle cells 
was abolished by voltage-gated calcium channel blockers, suggesting that Na+ entry through 
TRPC6 and the subsequent membrane depolarization induced much of Ca2+ influx 139. The 
expression levels of TRPC6 and TRPC3 in SPTB-Numb was approximately 100-fold and 36-
fold higher respectively compared to VT. Moreover, the SPTB-Numb display phenotypic 
characteristic similar to differentiated PC12 cells 27, which express high levels of L-type Ca2+ 
channels 140. Conceivably, it is possible that the involvement of TRPC6 in SOCE is mediated by 
secondary effects on membrane depolarization and activation of L-type Ca2+ channels.      
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During embryogenesis, Numb antagonizes the functions of Notch; however, Numb is 
expressed in many adult mammalian cells suggesting additional functions that may also be 
mediated by Notch. The biochemical mechanism by which Numb antagonizes Notch is not clear 
56, 122, 141, 142. It has been suggested that Numb interacts with NICD preventing its nuclear 
localization and therefore transcriptional activity 143. More specifically, Numb induces 
ubiquitination of Notch1 by recruiting the E3 ligase Itch, a process that requires the PTB domain 
of Numb 58. These data suggest that the Numb isoforms that differ in the PTB domain may 
differentially regulate Notch activity.  Indeed, we found increased levels of NICD in SPTB-
Numb compared to VT and LPTB-Numb. NICD was primarily localized to nucleus of SPTB-
Numb resulting in increased expression of HES-1, a known transcriptional target to Notch 
signaling. Therefore, it is possible that Notch may mediate the transcriptional upregulation of 
TRCP6 in SPTB-Numb. We used DAPT, a known γ-secretase inhibitor, to reduce the release of 
NICD, thereby attenuating Notch activity. Consistent with our hypothesis, DAPT reduced the 
expression of TPRC6 in SPTB-Numb. Furthermore, activation of Notch by jagged-1 peptide, a 
known Notch ligand, induced increases in TRPC6 expression in VT, confirming that Notch 
mediates the transcriptional upregulation of TRPC6 in SPTB-Numb. DAPT treatment in SPTB-
Numb also reduced ER calcium pool and attenuated [Ca2+]i in response to store depletion 
consistent with the changes in TRPC6 expression.  
Notch signaling plays an important role in cell differentiation, proliferation and apoptosis 
144, therefore we tested whether serum deprivation would enhance Notch activity in neural cells 
illuminating its role on TRPC6 transcriptional regulation. Serum deprivation increased the levels 
of NICD in neural cells and induced its nuclear translocation in a time-dependent manner 
consistent with the observed increases in the TRPC6 levels. Our results are in accordance with 
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previous findings where NICD levels were significantly elevated after cerebral ischemia in mice, 
while intravenous infusion of DAPT reduced NICD levels and ameliorated ischemia-induced 
brain damage 145.  
Interestingly, the changes in Notch activity and the concomitant upregulation in TRPC6 
were preceded by a significant switch in Numb isoform expression favoring the upregulation of 
the SPTB over the LPTB Numb isoform. This early upregulation of SPTB Numb isoform after 
serum deprivation supports the notion that Numb may modulate Notch activity in an isoform 
specific manner. Interestingly, LPTB-Numb suppressed serum deprivation-induced activation of 
Notch and the subsequent upregulation of TRPC6 and conferred protection against cell death. 
The latter finding further strengthens the link between the Numb isoform specific effect on 
Notch activation and the Notch-dependent upregulation of TRPC6. Numb colocalized with 
endocytic vesicles and was shown to directly bind to Notch as well as the ear domain of α-
adaptin 115. These findings dictate a role of Numb as an adaptor between α-adaptin and Notch 
promoting the down-regulation of Notch by endocytosis. We have shown that the PTB Numb 
isoforms differentially affect the sorting of APP to the recycling and degradative pathways 
(Kyriazis GA, et al., 2008). Accordingly, in SPTB-Numb Notch was found to accumulate in the 
early endosome where it was shown to colocalize with Rab5a, an early endosomal marker. It has 
been suggested that endocytosis is important in NICD release and signaling. For instance, 
inhibition of the late endosome can activate Notch signaling by redirecting its trafficking via the 
early endosomal compartments 146. Therefore, accumulation of Notch in early endocytic 
compartments may lead to its activation suggesting that γ-secretase activity occurs in places 
other than the cell surface 147. It is possible that the SPTB Numb isoform induces ectopic 
 71
activation of Notch by directing its sorting in compartments where γ-secretase-mediated 
proteolytic processing is present.  
In summary, we showed that Numb can modulate calcium homeostasis in an isoform-
specific manner by increasing the transcription of TRCP6 calcium channels. These effects of 
Numb are mediated by an isoform-specific regulation of Notch activity. Moreover, serum 
deprivation induces Notch activation and TRPC6 upregulation resulting in calcium dysregulation 
and cell death (Fig 20). The consequences of Notch-mediated TRPC6 regulation in disease 
models are not known yet.  Notch signaling is activated upon ischemic stroke suggesting a 
contribution of Notch to neuronal cell death 145. It is plausible that during stress Notch mediates 
its detrimental effects by specifically targeting TRPC6 and calcium homeostasis. Although, this 
is the first report showing that TRCP6 is a transcriptional target of Notch signaling, the precise 
transcriptional mechanism remains known. Finally, understanding the factors that regulate the 
alternative splicing of Numb proteins may serve as a molecular target to control the functions of 





































































Figure 20. Schematic diagram: SPTB-Numb affect the Notch-dependent upregulation of 
TRPC6 calcium channels   
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In pro-neuronal PC12 cells, serum deprivation selectivity upregulates the SPTB isoform 
of numb, favoring the shorting of Notch at early endosomal compartments, inducing an increase 
in NICD generation and Notch transcriptional activity. In turn, Notch mediates the 
transcriptional upregulation of TRPC6 calcium channels, which regulate calcium homeostasis 
via a store-operated calcium entry (SOCE) mechanism. The notch-mediated TRPC6 upregulation 
and its subsequent effects on calcium flux partly account for the serum deprivation- induced cell 
death in PC12 cells. 
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